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The skeletal muscle of severely obese individuals (BMI ≥ 40 kg/m2) is characterized by a 
depressed ability to oxidize fatty acids and a failure to upregulate fatty acid oxidation (FAO) in 
response to increased lipid availability, both of which may contribute to a positive lipid balance 
and weight gain.  The inability to switch from predominately glucose oxidation to FAO in the 
presence of a lipid challenge, such as a high-fat diet (HFD), is part of a defect in obesity known 
as metabolic inflexibility.  In severe obesity, ten consecutive days of aerobic training (short-term 
training) partially restores metabolic flexibility by increasing the ability of skeletal muscle to 
oxidize fatty acids.  The purpose of this dissertation was to determine a) whether contractile 
activity in human primary skeletal muscle cell culture (HSkMC) via electrical stimulation 
provides a model to investigate the mechanisms underlying the ability of short-term aerobic 
training to normalize FAO and provide some degree of metabolic flexibility in severely obese 
individuals and b) whether the metabolic inflexibility present in obesity is unique to a lipid 
challenge such as a HFD or whether obese individuals are also metabolically inflexible when 
  
 
 
challenged with carbohydrates (CHO) such as galactose or pyruvate.  The hypotheses were that 
1) HSkMC would provide a model to investigate how in vivo contractile activity increases FAO 
and markers of mitochondrial content in response to short-term aerobic training and 2) HSkMC 
from severely obese individuals would be metabolically flexible in response to galactose or 
pyruvate but would remain metabolically inflexible to a lipid challenge.  The results contained 
herein suggest that contractile activity in HSkMC for 48 h may be capable of mimicking some of 
the short-term training effects such as increased FAO; however, a longer electrical stimulation 
period is warranted to initiate changes in mitochondrial content and oxidative capacity.  
Although comparisons between lean and obese were not made in this study, the results and 
recommendations of the present investigation have laid the groundwork for future studies to 
investigate the effect of electrical stimulation on HSkMC established from severely obese 
individuals.   
In the second study of this investigation, HSkMC established from severely obese 
individuals were found to be metabolically flexible in response to 24 h incubations with lipid, 
galactose, or pyruvate as evidenced by an increase in state 3 palmitoyl-carnitine malate (PCM3) 
and FCCP stimulated respiration in response to all three substrates.  Citrate synthase activity and 
OXPHOS protein content also increased whereas glucose utilization decreased in response to 
substrate challenges in both lean and obese groups.  The volunteers in the second study were 
young and likely not far into the progression of metabolic disease, which may explain why 
metabolic flexibility remained intact in this population.  Although limited by the inability to fully 
recapitulate true physiological conditions, human primary skeletal muscle culture is a novel tool 
for investigations into the mechanisms underlying metabolic inflexibility in obesity. 
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CHAPTER 1: LITERATURE REVIEW 
Prevalence and Etiology of Obesity 
 The prevalence of obesity, which is defined as having a body mass index (BMI) ≥ 30 
kg/m2, is increasing at an alarming rate in Westernized societies and developing countries (146).  
In the United States the prevalence of obesity during the last 40 yrs among adults has increased 
from 11.9% to 35.5% in men and from 16.6% to 35.8% in women and severe obesity (BMI ≥ 40 
kg/m2) has increased from 0.6% to 4.4% and 2.1% to 8.2% in men and women respectively (53, 
54). 
 In and of itself, obesity may not directly cause metabolic disease (157, 185) but is 
permissive for the development of several chronic diseases including heart disease, type 2 
diabetes, hypertension, stroke, and certain types of cancer (206).  The risk of developing such 
chronic diseases is positively associated with the degree of adiposity with a linear increase in 
morbidity and mortality with body mass indexes ≥ 25 kg/m2 (201).  Individuals with severe 
obesity are at the greatest risk and can anticipate a reduction of 8-10 yrs in life expectancy 
compared to their lean counterparts (201).  
 Obesity is a complex multifaceted condition whose etiology is not fully understood, 
however, a central tenet of obesity is chronic energy imbalance, i.e., energy intake that exceeds 
energy expenditure over a prolonged period of time (75).  The two primary contributors to the 
positive energy imbalance present in the development of obesity are thought to be 1) decreased 
physical activity (81) and 2) excess caloric consumption (174, 175).  Our lifestyles have changed 
considerably over the recent past:  there has been a substantial decrease in the number of 
occupations requiring moderate amounts of physical activity (33), the amount of physical 
activity in our day-to-day lives has largely been engineered out of our environment through 
  
 
2
technological advances, and access to inexpensive energy-dense foods is abundant, and 
convenient (79, 139, 140).  Although energy imbalance is the generally accepted cause of 
obesity, some in the field have challenged this paradigm, suggesting there are instances in which 
energetic balance is achieved whereas macronutrient balance is not (5, 52, 80).  In this paradigm, 
the third contributor to the development of obesity is macronutrient balance, which can be 
summarized in the simple equation: Intake – Oxidation = Balance.  Carbohydrate and fat 
balances are intricately tied to one another, the preferential oxidation of carbohydrate or fat will 
contribute to a positive imbalance of the reciprocal macronutrient (80).  In theory, an 
overreliance on CHO oxidation is thought to result in a short-term positive fat balance.  Over 
time, these short-term positive fat balances may accumulate and translate into weight gain.  At 
the whole body level, the contribution of carbohydrate and fat can be calculated through the ratio 
of expired gases (O2 to CO2) known as the respiratory exchange ratio (RER) or respiratory 
quotient (RQ).  The RER ranges from 0.7 to 1.0 with 0.7, 0.85, and 1.0 indicating approximately 
100/0, 50/50, and 0/100 percentages of fat and carbohydrate utilization, respectively.  Zurlo et al 
(211) was one of the first investigators to demonstrate that an elevated fasting RQ was predictive 
of future weight gain in the Pima Indian population of Arizona.  Since then, other investigators 
have demonstrated that an elevated RQ is predictive of future weight gain in non-obese women 
(118, 119) and in a large cohort of men with ages ranging from 18-98 (164).  Although these 
short-term macronutrient imbalances may seem trivial, they are in line with evidence indicating 
that obesity is the result of relatively small daily positive energy imbalances with estimates 
ranging from 100 kcal/d (81) to 110-165 kcal/d (195).  The question must then be asked, if small 
macronutrient imbalances contribute to weight gain, what steps can be taken to correct them. 
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Skeletal Muscle Fatty Acid Oxidation 
 Fat free mass (FFM) is the largest contributor to resting metabolic rate (RMR).  Although 
skeletal muscle is not considered to be one of the most metabolically active tissues, by mass, it 
makes up to ~40-50% of FFM (58, 84) and therefore represents a substantial portion (~20-30%) 
of total oxygen consumption (210).  For a positive fat balance to occur, fat storage must exceed 
fat oxidation.  In our laboratory we have demonstrated that in severely obese individuals fatty 
acid oxidation (FAO) is reduced in muscle strips from rectus abdominus (88), muscle 
homogenates from the vastus lateralis (97), and whole body FAO using radiolabeled tracers 
(183).  A reduction in the ability to oxidize fatty acids will in turn promote fat storage, which 
may contribute to a positive fat balance.  Numerous investigators have shown that weight loss 
through dietary interventions drastically improves metabolic health but has little effect on the 
ability of previously obese individuals to oxidize fatty acids (5, 14, 94, 159, 183), leaving them 
prone to weight regain (5, 55, 118, 119, 191).   
 Our laboratory has also shown that 10 consecutive days of aerobic training rescues FAO 
by increasing skeletal muscle FAO in lean, obese, and previously obese individuals to the same 
extent (14), making exercise one of the few interventions to correct the impaired ability to 
oxidize fatty acids in the obese individual.  On the other hand, the ability of the skeletal muscle 
of obese individuals to respond to aerobic exercise training has been questioned by some (39, 
77).  The transcriptional coactivator, peroxisome proliferator-activated receptor-gamma 
coactivator 1 alpha (PGC-1α) is responsible for coordinately upregulating the transcription of 
genes of oxidative metabolism (205).  In lean, healthy individuals, PGC-1α mRNA transiently 
increases in response to aerobic training (144) whereas in obese insulin-resistant individuals this 
effect seems to be blunted (39).  In a related study, PGC-1α mRNA and markers of 
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mitochondrial content have also been shown to be unresponsive to 6 wk of aerobic training in 
obese individuals (77) although not all data supports this notion (123).  
 Metabolic Flexibility 
 The skeletal muscle of obese individuals is also characterized by the inability to match 
substrate oxidation with nutrient availability, which may also contribute to a positive fat balance.  
In the late 1990’s David Kelley’s group coined the term “metabolic flexibility” to describe the 
ability of lean individuals to match substrate oxidation with substrate availability during times of 
fasting and insulin stimulation (94, 96).  Obese individuals, on the other hand, are thought to be 
“metabolically inflexible” as they tend to remain overly reliant on CHO oxidation during fasting 
and less reliant during insulin stimulation.  Our laboratory (10, 22, 23) and others (5, 182) have 
also found that obese individuals exhibit impaired “metabolic flexibility” in the face of a lipid 
challenge.  For example, the imposition of a high fat diet increases PGC-1α mRNA, genes 
associated with lipid metabolism (22), and FAO (10) in lean, but not obese individuals.  In 
addition, our laboratory has also demonstrated that human primary skeletal muscle cells 
(HSkMC) from obese individuals fail to upregulate the capacity to oxidize fatty acids in response 
to a 24 h lipid incubation (23), suggesting a genetic or epigenetic component to the etiology of 
obesity.  Taken together, the inability to upregulate genes associated with oxidative metabolism 
and FAO in response to increased dietary fat or exercise may result in a positive lipid balance 
and leave the obese individual vulnerable to future weight gain.   
Specific Aims and Hypotheses 
 To determine whether obese individuals are resistant to stimuli involved in increasing 
mitochondrial content and FAO, two primary aims have been developed, both of which were 
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performed in HSkMC.  HSkMC provides an ideal experimental set up for studying muscle 
metabolism because it precludes the interfering actions of whole body, extramuscular effectors 
such as insulin, free fatty acids, and cytokines.  In addition, severely obese individuals possess a 
significantly reduced oxidative capacity and as such a diminished exercise tolerance.   
 The purpose of the first aim of this investigation was to develop an in vitro model of 
short-term exercise training (contractile activity) to determine whether contractile activity is 
capable of increasing markers of mitochondrial content and FAO in myotubes derived from lean 
and obese donors to a similar extent.  We hypothesized that in vitro contractile activity would 
provide a novel model to investigate the metabolic effects of short-term exercise training while 
minimizing many of the extramuscular effects and exercise intolerance inherent to the obese 
population.  
 The second aim of this investigation was to determine whether the obese individual 
remains metabolically inflexible in the presence of oxidizable substrates other than lipid.  We 
hypothesize that metabolic flexibility will be conserved in severely obese individuals in the 
presence of oxidizable substrates other than lipid and that metabolic inflexibility in severe 
obesity is unique to lipid handling.   
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CHAPTER 2:  CHRONIC ELECTRICAL STIMULATION OF HUMAN SKELETAL 
MUSCLE MYOTUBES AS A MODEL OF SHORT-TERM AEROBIC EXERCISE 
TRAINING 
Abstract 
 
 The skeletal muscle of severely obese individuals is characterized by an inability to 
oxidize fatty acids.  Ten consecutive days of aerobic training has been shown to reverse the 
decrement in fatty acid oxidation (FAO) to the point where there is no difference in FAO 
between lean and obese individuals.  To gain a better understanding of how contractile activity 
increases FAO in skeletal muscle we sought to establish an in vitro model of exercise training.  
Human skeletal muscle cell cultures (HSkMC) from lean individuals and C2C12 skeletal muscle 
cells were intermittently electrically stimulated for 3 h/d for 3-4 d or continuously stimulated for 
48 h according to protocols identified in the scientific literature.  Fatty acid oxidation, oxygen 
consumption, and protein content of OXPHOS enzymes were determined in HSkMC, and 
glucose and lactate concentrations in the media were measured.  Using the electrical stimulation 
parameters of 50 V 10 Hz (4 x 0.3 ms pulses delivered in 400 ms trains with 3.6 s recovery), a 
promising trend (1.3 fold increase in FAO, P = 0.12) was observed (n = 3); however, this trend 
was no longer evident (0.91 fold increase, P = 0.59) when increasing the sample size (n = 5).  
Using another intermittent protocol, we were unable to replicate the increase in COX IV protein 
observed by Uguccioni & Hood in either HSkMC (n = 4) or C2C12 myotubes (n = 10).  The 
aminoglycoside antibiotic, gentamicin, present in our culture media has been shown to alter 
calcium handling and contractility in cardiac cells.  We next sought to investigate whether 
gentamicin prevented electrically stimulated mitochondrial adaptations.  The protocols of 
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Donnelly et al (n = 3), Uguccioni & Hood (n = 2), and Burch et al (n = 3) were unable to 
increase COX IV protein in C2C12 cells, however, the protocol of Pinheiro et al (n = 2) 
significantly increased (P < 0.05) COX IV protein in the presence of penicillin/streptomycin but 
not gentamicin.  Additional experiments utilizing the Pinheiro et al protocol in HSkMC failed to 
increase COX IV or OXPHOS protein despite the absence of gentamicin from the culture media 
(n = 4).  Continuously stimulating HSkMC for 48 h significantly increased FAO (P < 0.05) 
despite no change in OXPHOS protein or respiratory capacity in permeabilized myotubes.  
During the 48 h stimulation period, media was changed every 12 h and media lactate 
concentration significantly increased (P < 0.05) in the electrically stimulated cells at every time 
point, signaling an increase in glycolytic metabolism.  The addition of lipid to the culture media 
during the 48 h stimulation period did not further enhance FAO beyond the presence of lipid 
alone (P > 0.05).  We conclude that 1) efforts should be made to enhance HSkMC maturation 
and excitability in future electrical stimulation investigations, 2) antibiotic should not be 
included in the culture media during stimulation, 3) continuous stimulation of 48 h is preferable 
to short term intermittent stimulation (3 h/d, 3 d) in terms of increasing FAO, and 4) continuous 
stimulation periods greater than 48 h may be required to increase mitochondrial content and 
oxidative capacity to be able to truly recapitulate the full effects of short-term in vivo aerobic 
training.  
 
Introduction 
 The skeletal muscle of severely obese (BMI > 40 kg/m2) individuals is characterized by 
severe insulin resistance (59), reduced mitochondrial content (36, 85, 97), and a decreased 
reliance on fatty acids as a fuel source (97).  The inability to oxidize fatty acids in severe obesity 
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is thought to be the result of reduced mitochondrial content and/or mitochondrial dysfunction 
(36, 85, 151, 152).  Weight loss through caloric restriction has been shown to drastically increase 
insulin sensitivity (184) despite unchanged oxidative capacity.  However, weight loss alone does 
not correct the impairment in fatty acid oxidation (FAO) observed in obesity, leaving formerly 
obese individuals prone to recidivism (14).  A recent study by Battaglia et al. (10) highlighted the 
obese individual’s vulnerability to a positive lipid balance as three days of a high-fat diet 
significantly increased FAO in lean individuals whereas the obese group experienced no change.  
Furthermore, when obese individuals undergo a short-term high-fat feeding, genes responsible 
for up-regulating lipid metabolism are insensitive (22), rendering the obese individual 
unresponsive to the lipid stimulus and at an increased risk of developing a positive lipid balance.  
Our laboratory has demonstrated that 10 consecutive days of aerobic training rescues FAO by 
increasing skeletal muscle FAO in lean, obese, and previously obese individuals to the same 
extent (14), making exercise one of the few interventions to correct the impaired ability to 
oxidize fatty acids in the obese individual.  On the other hand, the ability of the skeletal muscle 
of obese individuals to respond to aerobic exercise training has been questioned by some (39, 
77).  The transcriptional coactivator, peroxisome proliferator-activated receptor-gamma 
coactivator 1 alpha (PGC-1α) is responsible for coordinately upregulating the transcription of 
genes of oxidative metabolism (205).  In lean, healthy individuals, PGC-1α mRNA transiently 
increases in response to aerobic training (144) whereas in obese insulin-resistant individuals this 
effect seems to be blunted (39).  In a related study, PGC-1α mRNA and markers of 
mitochondrial content have also been shown to be unresponsive to 6 wk of aerobic training in 
obese individuals (77) although not all data supports this notion (123). 
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 Discovering the exercise-related mechanisms responsible for the improvement of fatty 
acid oxidation in obesity is of great importance in establishing and refining treatment options for 
severe obesity.  Ideally, the effects of exercise on the skeletal muscle of obese individuals would 
be studied in vivo.  However, there are a number of factors inherent to the obese subject that 
makes it difficult to study muscle metabolism including exercise intolerance, hyperinsulinemia, 
elevated plasma free fatty acids, and other endocrine and humoral factors.  The phenotypic traits 
of skeletal muscle are retained in culture, making human skeletal muscle cell culture (HSkMC) a 
suitable method for studying obesity and other metabolic diseases (15, 23, 67).  Furthermore, 
HSkMC provides a high throughput for studying the effects of inhibitors, the effect of various 
substrate incubations, and provides the ability to track muscle metabolism over time.  Therefore, 
the purpose of this investigation was to optimize an electrical stimulation protocol in cultured 
cells capable of mimicking short-term in-vivo exercise training.  In doing so, we would be able to 
study the effects of exercise in skeletal muscle cells of lean and severely obese individuals 
without the potential in vivo confounders inherent to the obese population. 
 
Methods  
Experimental Design.  The purpose of this investigation was to optimize an electrical 
stimulation protocol in cultured cells capable of mimicking short-term in-vivo exercise training.  
There are a number of electrical stimulation protocols in the published literature, many of which 
have been performed in immortalized cell lines such as C2C12s (27, 28, 35, 42, 56, 89, 121, 129, 
148, 181, 188, 190, 207) and L6 (208), chick (45), mouse (148), rabbit (103, 104) and rat 
primary cells (46, 48, 90, 128, 145, 154, 165, 172, 187, 190, 196) and recently in human primary 
skeletal myotubes (1, 26, 101, 107, 131).  Electrical stimulation has been utilized to investigate a 
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broad spectrum of research topics including calcium handling (48, 101, 103, 190), fiber type 
transformations (28, 45, 103, 104, 128, 129, 196), and glucose uptake (1, 107, 117, 129, 131, 
145).  The intent of this study was to optimize existing electrical stimulation protocols to mimic 
the effect of short-term aerobic exercise training.  In doing so, we would be able to study the 
effects of exercise in skeletal muscle cells of lean and severely obese individuals without the 
potential in vivo confounders inherent to the obese individual, such as exercise intolerance, 
endocrine, and humoral factors.  Of the numerous electrical stimulation protocols available in the 
published literature, only a handful of studies have measured mitochondrial (28, 89, 107, 131, 
188) or transcription factor (89, 188) protein responses to electrical stimulation that most closely 
resemble exercise training.  Therefore these protocols were selected to establish our cell culture 
model of exercise training. 
 
Human Subjects.  Skeletal muscle was obtained by percutaneous biopsy from the vastus lateralis 
of lean (body mass index <25kg/m2) male subjects ages 18-30.  Compared to lean individuals, 
obese subjects are more difficult to recruit and were therefore excluded from the initial 
development of the electrical stimulation model in HSkMC.  Participants filled out a medical 
history questionnaire to confirm they were free from disease, did not smoke, and were not taking 
any medications known to influence carbohydrate or lipid metabolism.  The experimental 
procedure and associated risks were explained, in detail, in written and oral format and informed 
consent was obtained. The study was approved by the East Carolina Policy and Review 
Committee on Human Research.  
 
Primary Human Skeletal Muscle Cell Culture (HSkMC).  The isolation and culturing of human 
primary skeletal muscle cells from biopsies was performed as previously described (15, 127).  
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Myoblasts were grown to ~80% confluence before deplating and freezing down in aliquots of 
~500 k cells in growth media supplemented with 0.05% DMSO.  Cell aliquots were allowed to 
slowly cool at -80°C in a “Mr. Frosty” (ThermoScientific, Nalgene) for 24 h before 
cryopreservation in liquid nitrogen.  After thawing cell aliquots and sub-culturing to ~90% 
confluence, differentiation was induced by replacing growth media with low-serum 
differentiation media (DMEM, 2% heat-inactivated horse serum, 0.5 mg/ml BSA, 0.5 mg/ml 
fetuin, and 50 µg/ml gentamicin or penicillin/streptomycin).  Media was changed every 48 h 
unless otherwise noted.  All human myotube experiments were performed on day 7 or 8 of 
differentiation. 
 
C2C12 Cell Culture.  C2C12 cells were obtained from the American Type Culture Collection 
(ATCC) and cultured in growth media (high-glucose DMEM supplemented with 10% FBS, 0.5 
mg/ml BSA, 0.4 mg/ml fetuin, 50 µg/ml penicillin/streptomycin) at 37°C in a humidified 
atmosphere of 5% CO2 and 95% O2 on an uncoated T-75 flask.  After reaching ~80% 
confluence, myoblasts were trypsinized and sub-cultured onto 6-well plates containing a 1% 
gelatin coating at a density of 80 x 103 cells per well.  After achieving ~90% confluence, 
differentiation was induced by replacing growth media with low-serum differentiation media 
(DMEM, 2% heat-inactivated horse serum, 0.5 mg/ml BSA, 0.5 mg/ml fetuin, and 50 µg/ml 
penicillin/streptomycin).  Media was changed every 48 h.  Experiments were initiated on day 5 
of differentiation and harvested on day 9.   
 
Chronic Stimulation of Myotube Cultures.  Two types of electrical pulse generators and two 
types of stimulator lids were utilized in this investigation.  Custom-made simulator lids and a 
bioreactor pulse generator were purchased from Kenneth Donnelly, PhD University of North 
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Carolina Chapel Hill (42).  The stimulator lids were designed to fit a six-well culture dish and 
consisted of 12 steel electrodes per plate with two electrodes per well.  Each electrode was 
placed approximately 20 mm apart and sat parallel to one another in the plate.  The pulse 
generator purchased from Donnelly et al (42) was capable of being programmed to produce pulse 
trains of various frequencies and lengths interspersed with varying periods of rest.  For that 
reason the bioreactor from Donnelly was programmed to mimic the electrical stimulation 
protocols of Burch et al (28) and Pinheiro et al (145) in addition to that of Donnelly et al (42).  
An amplifier was purchased to provide power (ROLLS Mosfet Power Amplifier 200 
Watt/70Volt RA21006) and maximize throughput.  The bioreactor and amplifier were capable of 
powering up to four stimulator plates at one time.  The stimulator plates containing steel 
electrodes purchased from Donnelly were utilized only in our initial experiments presented in 
Figure 2.1.  Thereafter the second set of stimulator plates utilized in this study, the C-Dish (ION 
Optix), containing carbon, rather than steel electrodes, were utilized in all subsequent 
experiments to more closely replicate other electrical stimulation protocols in the literature while 
also reducing the potential for toxic contaminants released from corrosion of the steel electrodes 
into the media (178).  The second pulse generator utilized, the CS Stimulator (Harvard 
Apparatus), is not capable of producing pulse trains interspersed with periods of rest.  However, 
the biphasic waves in the protocols of Irrcher et al (89), Uguccioni et al (188), and Nikolic et al 
(131) do not contain rest periods in-between pulse trains (i.e., the pulse is uniform and constant); 
therefore, the CS Stimulator was utilized to replicate these protocols.  All stimulation protocols 
were verified for pulse width, frequency, and voltage using an oscilloscope (PicoScope).  No 
difference in waveform was noted between the stimulation plates containing steel electrodes and 
carbon electrodes or between the carbon electrode plates. 
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 The duration of the cell stimulation protocols can be further categorized as intermittent or 
continuous.  For example, protocols consisting of 3 h of electrical stimulation followed by 21 h 
of quiescence and another 3 h of electrical stimulation are classified as intermittent.  Other 
protocols are classified as continuous as there are no periods of quiescence and electrical 
stimulation runs continuously for 48 h.    
 For all intermittent stimulation experiments, electrical stimulation was initiated on day 4 
(HSkMC) or day 5 (C2C12) of differentiation.  Differentiation media was changed (2 ml) 1 h 
prior to the start of electrical stimulation and the plates were fitted with the stimulator lids.  The 
stimulation bouts lasted 3 h unless otherwise noted.  After each bout of stimulation, the 
stimulator lids were removed and the cells remained quiescent until the media was again changed 
1 h prior to the next stimulation bout.  All cell harvesting was performed 15-21 h after the last 
stimulation bout unless otherwise noted to distinguish between the acute effects of the last 
stimulation bout and the accumulated effects of the repeated bouts (89). 
 
Lipid oxidation. On day 7 of differentiation, myotubes were incubated for 3 h at 37⁰ C in sealed 
24-well plates containing differentiation media, 12.5 mmol/l HEPES, 0.5% BSA, 1 mmol/l L-
carnitine, 100 µmol/l sodium oleate or 250 µmol/l sodium oleate (Sigma-Aldrich, St Louis, MO), 
and 1 µCi/ml [14C] oleate (PerkinElmer, MA).  Following incubation, the medium was assayed 
for 14CO2 to measure complete fatty acid oxidation as previously described (127).  Cells were 
washed twice with PBS, harvested in 200 µl of 0.05% SDS lysis buffer, and stored at -80⁰C for 
determination of protein concentration. 
 
Respirometry experiments.  Myotubes were washed 2x with PBS and lifted from six-well culture 
dishes with 0.05% trypsin EDTA.  This reaction was neutralized by adding 10% FBS to the cell 
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suspension and centrifuged for 10min at 1000rpm at room temperature.  The cell pellet was 
then resuspended in growth media, counted using a hemocytometer, centrifuged again for 10 
min, and re-suspended in room temperature respiration buffer (130mM sucrose, 60mM 
potassium gluconate, 1 mM EGTA, 3mM magnesium chloride, 10mM potassium phosphate, 
20mM HEPES, 0.1% BSA; pH 7.4).  The cells were then treated with 3 µg/106 cells/ml 
digitonin (i.e., a mild, cholesterol-specific detergent) for 5 min at 37° C on an orbital shaker. 
This procedure selectively permeabilizes the sarcolemmal membranes while keeping 
mitochondrial membranes, which lack significant levels of cholesterol, completely intact.  
Following permeabilization, the myotubes were washed by centrifugation at 1000 rpm for 5 min 
to remove endogenous substrates in cells.  The cells were then resuspended in respiration buffer 
at a concentration of (3.0 × 106cells per 2.2ml) and loaded into a respiration chamber (Oroboros 
Oxygraph-2K, Oroboros Instruments Corp., Innsbruck, Austria). Once oxygen concentration flux 
stabilized, substrates were sequentially added in the following order GM – glutamate [10mM] 
malate [2mM]; ADP [4mM]; Cyto C – cytochrome C [10µM]; S – succinate [10mM]; FCCP - 
Carbonyl cyanide p trifluoro methoxyphenylhydrazone [2µM].  Side-by-side experiments for 
Control and Stimulation were performed on cells from each subject. The most stable portion of 
the oxygen concentration slope was determined for each condition and normalized to cell count 
as in previous cell culture respiration studies (30, 50, 143). 
 
Protein content. Cells were harvested in 100 µl ice-cold lysis buffer (50 mM HEPES [pH 7.4], 
10 mM EDTA, 100 mM NaF, 12 mM Na pyrophosphate, 1% Triton X-100) supplemented with 
protease and phosphatase inhibitors (Sigma-Aldrich).  Samples were sonicated, rotated end-over-
end at 4° C for 1 h, and centrifuged at 20,000 g for 30 min at 4° C.  Protein concentrations were 
determined using the bicinchoninic acid (BCA) assay (Pierce Biotechnology, Rockford, IL). 
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Twenty micrograms of protein were separated by SDS-PAGE and electrotransferred to 
polyvinylidene fluoride (PVDF) membranes (Millipore, Billerica, MA) and probed overnight for 
cytochrome c oxidase (COX) IV (1:1000; Cell Signaling, Beverly, MA) and with a cocktail 
containing antibodies against the following proteins (1:1000): Complex I subunit NDUFB8, 
Complex II subunit 30kDa, Complex III subunit Core 2, Complex IV subunit II, and ATP 
synthase subunit alpha (MitoSciences, Eugene, OR).  Membranes were incubated for 1 h at room 
temperature with the corresponding secondary antibody and the immunoreactive proteins were 
detected using enhanced chemiluminescence (ChemiDoc XRS+ Imaging System, BioRad 
Laboratories, Inc., Hercules, CA).  Samples were normalized to a crude cell sample on each gel 
to normalize for blotting efficiency across gels.   
 
Glucose and Lactate Determination.  Starting on day 6 of differentiation, media samples were 
collected every 12 h and immediately frozen at –80° C for the subsequent determination of 
glucose and lactate.  Glucose and lactate were determined by oxidation reaction (YSI model 
2300 Stat Plus; Yellow Springs Instruments, Yellow Springs, OH). 
 
Statistical Analyses. Data are presented as mean ± SEM.  Statistical analyses were performed 
using a 1-way ANOVA with Student-Newman-Keuls methods for analysis of significance 
among groups.  The level of significance was set at P < 0.05. 
 
Results 
Videos of Myotube Contraction. Videos demonstrating myotube contraction under electrical 
pacing are available in the supplementary materials. Contracting human skeletal muscle 
myotubes paced with electrical pulses of 50 V 10 Hz (4 x 0.3 ms pulses delivered in 400 ms 
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trains with 3.6 s recovery) are demonstrated in Videos 2.1 & 2.2.  Contracting C2C12 myotubes 
paced with the identical electrical stimulation parameters can be observed in Videos 2.3 & 2.4. 
The Effect of Electrical Stimulation on Fatty Acid Oxidation with Methods adapted from 
Donnelly et al.  To assess whether contractile activity in vitro would increase fatty acid oxidation 
(FAO), HSkMC were electrically stimulated 3 h/d for 3 d with stimulation parameters modified 
from Donnelly et al. (42) (50 V, 10 Hz, provided as 4 x 0.3 ms pulses delivered in 400 ms trains 
with 3.6 s recovery).  FAO was measured 21 h following the last bout of stimulation to 
discriminate between the acute and chronic effects of stimulation (89, 188).  We observed an 
initial trend (P=0.12) for FAO to increase in response to repeated electrical stimulation for 3 h/d 
for 3 d (Figure 2.1A).  When we repeated these experiments the trend diminished (Figure 1B-C), 
however, when the outlier was removed from the data set, the trend reemerged (P=0.10) (Figure 
2.1D).  A larger sample size is necessary to determine whether this protocol is effective in 
increasing FAO in HSkMC.  Additional experiments to determine whether this protocol was 
capable of effectively increasing FAO are not reported here as the technique utilized in our 
laboratory to measure FAO began producing inconsistent and unreliable results.  The 
scintillation counts used to determine FAO decreased by a magnitude of four to five fold.  
Therefore, we felt the results produced by this technique were unreliable and the assay had lost 
its sensitivity to detect meaningful change.  Despite numerous attempts to troubleshoot this 
technique over the course of the next six months, we were unable to re-establish this technique.  
To that end we were forced to move on to a different direction.  The work of Uguccioni & Hood 
(188) provided an alternative protocol to address the aims of our project. 
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The Effect of Electrical Stimulation on Mitochondrial Content and Protein Synthesis with 
Methods adapted from Uguccioni & Hood.  In addition to increasing the rate of FAO in skeletal 
muscle, exercise training is also known to increase mitochondrial content.  In developing a cell 
culture model of short-term aerobic exercise training, we sought to utilize a protocol known to 
stimulate FAO and/or mitochondrial content.  The electrical stimulation protocol of Uguccioni & 
Hood (3 h/d, 5 Hz, 9V, 4 d) has been shown to increase COX IV protein and the mitochondrial 
transcription factor A (TFAM) by 3.9 and 2.3 fold in C2C12 cells (188). When this protocol was 
applied to HSkMC, we observed no increase in COX IV protein (Figure 2.2A).  Although we 
expected COX IV protein to increase in response to this protocol, a single protein does not 
provide an all encompassing picture of total mitochondrial content.  Therefore, to assess a 
broader range of proteins we measured mitochondrial content using the OXPHOS cocktail 
(MitoSciences, Eugene, OR), which contains an antibody for a subunit of each complex of the 
respiratory chain.  Here, we observed no difference in subunits from Complexes II, III, and V, 
and actually observed a significant decrease in protein from the subunits of Complexes I and IV 
(P<0.05) in the electrically stimulated cells (Figure 2.2B). 
 The pulse generator, stimulation lids, and cell type utilized by Uguccioni and Hood (89, 
188) were different from those used in our study.  To assess whether the electrical stimulation 
set-up or cell type may have affected the ability to replicate the findings of Uguccioni and Hood 
(188), we electrically stimulated C2C12 myotubes 3 h/d for 4 d and again found no increase in 
COX IV protein (Figure 2.3A).  There was also no increase in Complex I, II, III, or V proteins 
with electrical stimulation (Figure 2.3B), indicating the protocol did not have a significant effect 
on mitochondrial content. 
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 Aerobic training and strength training are traditionally thought to elicit divergent 
responses, i.e. increased oxidative capacity or increased synthesis of myofibril proteins.  In 
isolated rat muscle, Atherton et al (6) demonstrated that altering the frequency of stimulation, 10 
Hz versus 100 Hz, resulted in aerobic and resistance training like responses, respectively. To 
assess whether the conditions of our experimental set-up and stimulation parameters were 
activating the protein synthesis pathways associated with resistance training, we measured 
several proteins involved in the regulation of protein synthesis (AKT-1, eEF2, mTOR, p70-S6, 
and 4E-BP1).  Electrical stimulation did not increase these proteins (Figure 2.3C). 
The Interaction of Electrical Stimulation and Antibiotic on Mitochondrial Protein in Skeletal 
Muscle Cells.  The use of antibiotics in cell culture media is a standard practice to prevent 
bacterial and/or fungal contamination.  Two of the most common antibiotics in tissue culture, 
gentamicin and streptomycin, are in a class of antibiotics known as aminoglycosides.  Although 
aminoglycosides are highly effective in preventing bacterial contamination, a major limitation of 
their use in tissue culture is altered calcium kinetics and decreased contractility (44, 76, 114).  
On the other hand, the antifungal agents commonly used in tissue culture, Amphotericin B and 
penicillin, seem to have little effect on muscle contraction (131).  Although both gentamicin and 
streptomycin decrease contractility, streptomycin is thought to be less potent in inhibiting 
contraction (12), therefore in our next set of experiments we sought to investigate whether 
replacing gentamicin with streptomycin would augment the response to our contraction stimulus.  
To that end we cultured C2C12 myotubes in either a) gentamicin/Amphotericin B or b) 
penicillin/streptomycin and electrically stimulated them according to the protocols of Uguccioni 
& Hood (188), Burch et al (28), Donnelly et al (42), and Pinheiro et al (145).  Neither, the type 
of antibiotic, or the electrical stimulation protocol had any effect on COX IV protein using the 
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protocols of Uguccioni & Hood (188), Burch et al (28), or Donnelly et al (42) (Figures 2.4A, B, 
and C) whereas COX IV protein significantly increased (P < 0.05) with the protocol of Pinheiro 
et al in the presence of penicillin/streptomycin but not gentamicin (Figure 2.4D). These data 
suggest that, during these conditions, gentamicin was prohibiting some of the mitochondrial 
adaptations we were attempting to initiate.  Follow up experiments using the protocol of Pinheiro 
et al in HSkMC failed to increase proteins from Complexes I, III, or V as well as COX IV 
protein despite the absence of gentamicin from the culture media (Figure 2.5). 
The Effect of Continuous 48 h Electrical Stimulation on Glucose and Lactate Content in the 
Media, Mitochondrial Protein Content, and Oxygen Consumption.  Initially, we only utilized 
intermittent electrical stimulation protocols because they most closely resemble the physiological 
demands of exercise in vivo (28, 42, 145, 188), that is, exercise bouts interspersed with periods 
of rest.  However, these protocols were ineffective in eliciting training-like adaptations.  
Continuous, uninterrupted (24-48 h), electrical stimulation offers an alternative to intermittent 
contractile bouts and has been shown to increase some indices of mitochondrial content (28, 107, 
131).  Several investigators have also demonstrated that continuous stimulation enhances 
myotube maturation (56, 107, 129) by optimizing sarcomere alignment.  We hypothesized that 
by electrically stimulating HSkMC continuously over the course of 48 h, components of the 
excitation contraction machinery would become more mature/aligned, thereby increasing the 
number of cells recruited during the course of stimulation and increasing energy demand.  To 
assess whether electrical stimulation was increasing energy demand and utilization, we measured 
glucose and lactate in the cell media at baseline and at 12 h intervals up to 48 h.  As expected we 
observed a significant increase in lactate accumulation in the stimulated cell media at all time 
points post baseline (P < 0.05) (Figure 2.6A).  However, we did not observe a significant effect 
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of time, potentially indicating our continuous stimulation was not further inducing sarcomeric 
development and muscle cell recruitment differentiation.  Interestingly we observed no 
difference in media glucose concentration between groups at any time point (Figure 2.6B).  To 
determine whether our intervention affected the oxidative capacity of the myotubes we measured 
OXPHOS protein content and respiration immediately after the 48 h stimulation bout.  There 
were no differences between control and stimulated cells in either OXPHOS protein content 
(Figure 2.6C) or oxidative capacity (Figure 2.6D). 
The Effect of Lipid and 48 h Continuous Electrical Stimulation on FAO in HSkMC.  Skeletal 
muscle increases the rate of FAO during aerobic exercise (192).  The increased demand for fatty 
acids during exercise training is met from the mobilization of fatty acids from adipose stores and 
the breakdown of intramuscular triglyceride stored within the skeletal muscle.  In the culture 
model there is a very limited amount of lipid available in the media (68).  To more accurately 
resemble the energetic environment of skeletal muscle during rest and exercise, 100 µM 
oleate/palmitate (O/P) was added to the cell media for 48 h, with (Stim w/Lipid) and without 48 
h of continuous electrical stimulation (Lipid).  In the present investigation our initial question 
was whether electrical stimulation was capable of mimicking short-term exercise training by 
increasing FAO in HSkMC.  The radiolabeled FAO procedure is the most effective tool in 
answering this question but was abandoned after the technique became unreliable (Figures 2.1A-
D).  Here we reinitiated our troubleshooting attempts and were successful in re-establishing the 
radiolabeled FAO technique.  Lipid, electrical stimulation (Stim), and Stim w/Lipid significantly 
increased FAO (P < 0.05) above control values (Figure 2.7A-B).  FAO was greater in Lipid and 
Stim w/Lipid (P < 0.05) compared to stimulation alone.  There was no difference in FAO 
between Lipid and Stim w/ Lipid, suggesting the presence of lipid during electrical stimulation 
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did not further enhance FAO; the increase in FAO with electrical stimulation was similar under 
control (16%) and lipid (22%) conditions (Figure 2.7B & C).   
 
Discussion 
 The purpose of this investigation was to create an electrical stimulation model in cultured 
human skeletal muscle cells (HSkMC) capable of replicating the metabolic adaptations to short-
term exercise training observed in vivo.  Developing such a model would be advantageous in 
understanding the molecular responses to exercise training without the conflicting effects of 
neuro-endocrine and exercise intolerance concerns observed in the obese population. 
 Although the results of the current investigation do not establish a model of exercise 
training in culture, a closer examination of the data in this investigation and previously published 
literature reveals several key observations: 1) the lack of standardized culture conditions and 
electrical stimulation parameters contribute to inconsistent electrical stimulation outcomes, 2) the 
evidence for short-term in vitro intermittent (3 h/d, 3-4 d) electrical stimulation to enhance 
oxidative enzyme content or activity is scarce and difficult to reproduce (89, 188),  3) continuous 
electrical stimulation of 48 h is capable of increasing FAO, and 4) periods of continuous 
stimulation in skeletal muscle myotubes greater than 48 h may be required to enhance 
mitochondrial content and oxidative capacity characteristic of in vivo short-term aerobic exercise 
training. 
Methodological Considerations for Electrical Stimulation of Skeletal Muscle Cells in Culture.  
There is a vast array of electrical stimulation protocols in skeletal muscle cells in the published 
literature.  The combination of inherent differences in skeletal muscle characteristics among cell 
types including excitability, capacity to differentiate, and an infinite number of electrical 
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stimulation permutations and variables contribute to inconsistent electrical stimulation outcomes.  
For example, a number of key parameters vary considerably among electrical stimulation 
investigations in the published literature: the frequency of stimulation ranges from 0.25 to 100 
Hz, voltage from 4 to 65 V, pulse width from 0.15 to 24.00 ms, and hours of stimulation from 
1.5 to 48 hrs (Table 2.1).  Other important considerations include but are not limited to the 
number of stimulation days, the day of differentiation to begin stimulation, the length of the 
electrical pulse train and rest period, the amount of electrical current, material of the plate matrix, 
antibiotic selection, serum type and concentration of the media, electrode material, distance 
between electrodes, time of measurement, and the type of pulse generator and plates.  It is 
understandable that diverse research questions require distinct electrical stimulation parameters, 
however, the sheer number of variables involved in the electrical stimulation of cultured cells 
highlights the difficulties in reproducing meaningful results between and within laboratories. 
 There are a number of custom made (1, 35, 103, 104, 131, 188) and commercially 
available electrical stimulation pulse generators utilized in electrical stimulation studies with the 
most common commercially available stimulators being the C-Pace EP (IonOptix, Milton, MA) 
and Grass Stimulators (Grass Technologies, Warwick, RI).  The type of stimulator should not 
make an appreciable difference in electrical stimulation results as voltage is typically verified 
with an oscilloscope.  The type of electrode utilized in the experiments will, however, affect how 
efficiently the current is transferred through the cell media.  There are several commonly used 
electrodes composed of various materials including copper, brass, titanium, stainless steel, 
platinum, and carbon (117, 178) each possessing different charge transfer characteristics.  This is 
important to note because although voltage is reported in the literature, current typically is not. 
Voltage is a measure of the difference in electrical potential between two electrodes but provides 
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no indication of how efficiently the charge is transferred to the media or the cultured cells (29, 
177, 178).  Manabe et al (117) found that copper, brass, and platinum electrodes did not cause an 
efficient contraction in C2C12 cells, although carbon electrodes did.  In contrast, numerous 
investigators have found platinum electrodes to be effective in inducing metabolic responses, 
including Ca2+ transients (103, 190) and glucose uptake (1, 145, 190), measures that Manabe et 
al (117) reported.  With that being said, the field seems to be promoting carbon electrodes as the 
gold standard due to their superior charge transfer characteristics and lack of electrode corrosion 
(177, 178).  In addition, several recent investigations utilizing carbon electrodes have been 
successful in electrically stimulating human primary skeletal muscle cells (107, 131, 180), 
therefore the use of carbon electrodes is warranted in future electrical stimulation investigations. 
 The type of antibiotics in the cell culture media may also play a role in the response to 
electrical stimulation.  The use of antibiotics is a standard practice to prevent bacterial and/or 
fungal contamination. The two most commonly used antibiotic combinations in tissue culture are 
a) gentamicin and another agent such as Amphotericin B or b) a combination of 
penicillin/streptomycin (P/S).  Amphotericin B and penicillin function as antifungal agents 
whereas gentamicin and streptomycin are classified as aminoglycosides whose purpose is to 
prevent bacterial contamination.  Although aminoglycosides are highly effective in preventing 
bacterial contamination, a major limitation of their use in muscle tissue is altered calcium 
kinetics and decreased contractility (44, 76, 114).  Although both gentamicin and streptomycin 
decrease contractility, streptomycin is thought to be less potent in inhibiting contraction (12).  To 
determine whether antibiotics were affecting our electrical stimulation results we utilized a 
combination of (P/S) in a number of intermittent stimulation trials (Figure 2.4A-D) and found 
that in the presence of P/S, the Pinheiro et al (145) electrical stimulation protocol significantly 
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increased COX IV whereas the presence of gentamicin completely abolished this effect (Figure 
4C).  When the Pinheiro protocol was repeated in HSkMC, there was no increase in COX IV 
protein, underscoring the importance of differences between cell types.  In the literature there are 
reports indicating positive results in electrical stimulation studies with (117, 131, 188) and 
without (107, 180) the presence of penicillin/streptomycin.  However, there are no published 
reports in which gentamicin was the antibiotic utilized, therefore, one of the main findings of this 
work was the indication that it may be fruitful to utilize penicillin/streptomycin or no antibiotic 
when utilizing electrical stimulation in cell culture systems. 
 The inherent properties of the type of myocyte utilized may also have a large impact on 
whether the electrical stimulation protocol induces a desired response.  Burch et al (28) reported 
that SOL8 cells, an immortalized cell line from mouse soleus, did not increase PGC-1α mRNA 
in response to their electrical stimulation protocol (24 h, 50 Hz 14V, 1 sec pulse 1 sec rest) and 
that mouse primary cells did not survive their protocol whereas C2C12 cells demonstrated a 
robust PGC-1α mRNA response.  Manabe et al (117) also found that C2C12 cells responded to 
their stimulation protocol by efficiently contracting whereas L6 cells did not.   
 Differences in the degree of excitability between cultured cell lines may have prevented 
any appreciable change in the desired metabolic outcomes in the present investigation.  It is well 
documented that the excitability of cultured cells is greatest in rat and mouse primary cells and 
that C2C12 cells possess  “exceptionally low excitability” (41).  The excitability of HSkMC is 
several orders of magnitude less excitable than C2C12 cells (Supplementary Videos).  Manabe et 
al (117) estimated that approximately 80% of C2C12 myotubes contracted upon electrical 
stimulation.  In the present investigation, we estimate C2C12 contraction to be 50-75% of 
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myotubes, while HSkMC contraction was rarely ≥ 10% with no visible contraction noted on 
some occasions.  
 The degree of muscle tissue excitability is regarded as an effective marker of muscle 
maturation (41).  The low level of excitability in HSkMC is most likely due to a poor degree of 
maturation and is a reflection of its primitive state.  Human primary skeletal muscle cells are not 
simply adult muscle cells in a culture plate.  There are a number of transitional stages of 
development immature skeletal muscle cells must undergo to reach the adult state.  For example, 
the development of skeletal muscle in vivo is characterized by the sequential expression of 
embryonic, neonatal, and adult myosin heavy chain (MHC) forms (9).  In culture, human 
primary myotubes are in their infancy.  For example, comparative gene expression profiling 
between human primary myotubes and adult skeletal muscle shows that genes associated with 
mitochondrial pathways of energy production, myofilaments, and calcium handling are all 
downregulated in cultured cells (150).  Dennis & Dow (41) found that the degree of skeletal 
muscle tissue excitability in rodents was proportional to the degree of muscle maturation.  
Excitability increased at each step of the development process starting with rat primary skeletal 
muscle cells, followed by neonatal muscle of 10-14 d, 25 d, and 40-44 d, and greatest in adult 
skeletal muscle (41).  Compared to skeletal muscle cells from chicken, rat, and mouse, human 
primary skeletal muscle cells are thought to differentiate less rapidly and less completely than 
their animal counterparts (40).  Furthermore, based upon myotube excitability, it appears that rat 
and mouse primary cells, as well as those of immortalized cell lines may be capable of reaching a 
more terminal degree of differentiation in culture than HSkMC.   
 Another factor that may be affecting the results of studies in HSkMC is myotube 
heterogeneity.  Compared to immortalized cell lines, the differentiation of primary cells is 
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considered to be heterogeneous (18, 115), which is thought to contribute to a considerable degree 
of variability in experimental results (18, 115, 117).  In the present study, only the most highly 
differentiated myotubes would visually contract upon electrical stimulation.  When variations of 
numerous electrical stimulation protocols were applied (> 25 variations) the myotubes capable of 
contracting would do so regardless of the stimulation parameters, provided the voltage was 
greater than a minimum threshold of 1.5 V (unpublished observations).  These observations, 
along with the vast number of published electrical stimulation protocols, suggest that an optimal 
stimulation protocol has not yet been achieved, and furthermore may not be necessary to 
develop.   
 It may be beneficial to identify ways to increase HSkMC differentiation to increase the 
number of myotubes capable of contracting with sufficient stimuli.  There are a number of 
options for increasing the degree of myotube differentiation in cultured skeletal muscle cells 
including replacing the horse serum in the differentiation media with fetal calf serum (66) or the 
serum substitute Ultroser G (13, 65, 69, 147), adding insulin like growth factor-1 (IGF-1) (91) or 
a cholinergic agonist (102) to the differentiation media, or changing the culture plate matrix from 
collagen to extracellular matrix gel (ECM-gel) (65) or Matrigel (46, 108).  Each of these factors 
has been shown to greatly enhance skeletal muscle differentiation, however it is unknown 
whether the enhanced differentiation translates into a more robust contraction.  Collectively, it 
appears as though efforts should be made to enhance myotube differentiation to increase the 
effectiveness of the electrical stimulation protocol. 
 The removal of serum from the media during the electrical stimulation period may also 
aid in obtaining a more terminally differentiated culture by reducing the percentage of myoblasts.  
For example, Lambernd et al (107) significantly increased OXPHOS protein after just 24 h of 
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stimulation in HSkMC after serum starving the night before and during the 24 h of stimulation.  
In normal culture conditions, the removal or reduction of serum from the media inhibits 
myoblast proliferation and induces myogenesis (98).  Although a reduction in serum promotes 
myoblast differentiation, a subset of cells are resistant to differentiation and remain myoblasts 
(18, 209).  In addition, electrical stimulation of myocyte cultures (26, 135) and stretching (194) 
are known to enhance myoblast proliferation.  It is possible that any measureable effects of 
electrical stimulation on myotube cultures are, in effect, “drowned out” by the proliferating 
myoblasts.  Taken together, serum starvation provides a favorable environment for electrical 
stimulation to enhance myotube maturation while at the same time limiting myoblast 
proliferation. 
Mitochondrial Responses to Electrical Stimulation in Culture - Intermittent Electrical 
Stimulation.  Although there are a number of electrical stimulation investigations in cell culture, 
only a handful of these studies have assessed mitochondrial protein or activity (28, 89, 90, 107, 
131, 188), and of this subset, only the Hood laboratory (89, 188) has reported increased 
mitochondrial content (in C2C12 cells) in response to intermittent stimulation protocols of 3 h/d 
for 2-4 d.  In the current investigation, we were unable to replicate the findings of Uguccioni & 
Hood (188) (5 Hz, 9 V) in HSkMC or C2C12 myotubes.  In the current investigation, 5 Hz, 9 V 
may have actually decreased the oxidative machinery in HSkMC as indicated by decreased 
Complex I and IV subunit protein (Figure 2.2B).  Other investigators have reported that high 
voltage or frequencies above 3 Hz will result in tetanus (personal observations, 17) and kill 
C2C12 muscle cells (42).  In another of Hood and colleagues’ electrical stimulation studies, they 
(89) reported utilizing 5 Hz and 55 V to promote mitochondrial biogenesis.  When 5 Hz and 30 
V were applied to HSkMC in the current investigation mitochondrial content was not measured 
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because the myotubes were badly damaged after 1 d of stimulation and completely destroyed 
after 2 d (data could not be collected).  The published accounts of intermittent electrical 
stimulation capable of increasing oxidative capacity (89, 188) were either not reproducible 
(present investigation) or resulted in cell death (17).   
 In addition to the Hood studies, three alternative intermittent protocols utilized in this 
investigation failed to increase mitochondrial content (28, 42, 145).  The Donnelly et al. (42) 
protocol was originally utilized as a single, 3 h acute bout in C2C12 cells to demonstrate the 
protocol’s effectiveness in studying metabolic responses to contractile activity.  The efficacy of 
their protocol was verified by demonstrating an increase in CAMKII and AMPK 
phosphorylation as well as an increase in PGC-1α mRNA (142), all of which are classic 
responses to in vivo contractile activity (8).  These same investigators later observed a similar 
increase in PGC-1α mRNA in electrically stimulated human primary myotubes (data not shown), 
demonstrating that, like immortalized cell lines, cultured human skeletal muscle cells are also 
metabolically responsive to this stimulation protocol.  PGC-1α is a powerful regulator of 
oxidative phosphorylation and β-oxidation genes, therefore we hypothesized that by expanding 
the original protocol to encompass three bouts of electrical stimulation rather than one, we would 
observe an increase in FAO and/or mitochondrial content in human primary myotubes.  In 
addition to Donnelly et al (42), Burch et al (28) previously demonstrated a transient increase in 
PGC-1α mRNA in response to electrical stimulation, however in the current investigation neither 
protocol translated into increased mitochondrial protein content (Figures 2.4B & D).  The 
duration of electrical stimulation (3 h/d, 3 d) may have been insufficient to increase 
mitochondrial content.  When the Burch et al protocol (28) was applied continuously for 24 h in 
C2C12 cells, PGC-1α, cytochrome c, and medium chain acyl-CoA dehydrogenase protein 
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increased.  It is remains unclear whether short-term intermittent stimulation is a feasible model 
for studying mitochondrial biogenesis in HSkMC. 
Mitochondrial Responses to Electrical Stimulation in Culture - Continuous Electrical 
Stimulation.  Initially, only intermittent electrical stimulation protocols (28, 42, 145, 188) were 
utilized in the current investigation as they more closely resemble the physiological demands of 
exercise in vivo, however, these protocols were ineffective in eliciting mitochondrial adaptations.  
Although not as physiologically relevant, continuous, uninterrupted (24-48 h), electrical 
stimulation has been shown to increase some indices of mitochondrial content (28, 107, 131), 
enhance sarcomeric development and alignment (56, 107), and in some cases facilitate a 
transition to a more oxidative fiber type (28, 45, 131, 196).  In the current investigation, 48 h of 
electrical stimulation failed to increase OXPHOS protein (Figure 2.6C).  In contrast to our data, 
Nikolic et al (131) reported increased mitochondrial content as visualized with MitoTracker after 
48 h of stimulation in HSkMC.  However, these data must be interpreted with caution, as the 
same investigators failed to report changes in citrate synthase activity (CS) or the OXPHOS 
proteins.  The duration of the Nikolic et al (131) intervention and that of the present investigation 
may not have been of a sufficient duration to increase mitochondrial content.  In a 7-10 d training 
study in humans, Battaglia et al (10) observed no increase in OXPHOS protein or β-HAD 
activity, whereas CS activity did increase in skeletal muscle tissue.  On the other hand, several 
investigators have noted no increase in several indices of mitochondrial content (SDH, CS, β-
HAD) after short-term exercise training for 3 d (70), 5 d (141), 5-7 d (72), or 10-12 d (74) 
whereas longer training durations of 14 d (176) and 31 d (141) robustly increase mitochondrial 
content in skeletal muscle tissue.  In the culture system, long-term electrical stimulation may be 
required to produce oxidative changes; however, this may not be feasible as HSkMC are thought 
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to possess a finite (3-4 d) experimental lifespan (66).  On the other hand, skeletal muscle cells 
cultured from embryonic chick breast muscle (45) and the hindlimb musculature of newborn rats 
(128) have been electrically stimulated in culture for up to 19 and 20 days respectively.  Human 
skeletal muscle myotubes are capable of being maintained in culture for up to three weeks (13, 
170) and, with such an extended culture duration, more closely resemble adult muscle in terms of 
enzymatic activity and myosin heavy chain than do their 7 d differentiated counterparts.  
However it is unclear whether these cells are capable of withstanding the forces imposed by 
electrical stimulation without lifting from the culture plate.  After 24 and 48 h of electrical 
stimulation there is a noticeable amount of cell lifting off the culture plate, however there are no 
appreciable differences in total protein content between control and stimulated cultures (data not 
shown).  A potential area for future investigations to pursue in developing a short-term training 
contractile activity model in HSkMC may be to extend the culture beyond 7 or 8 days of 
differentiation and subsequently electrically stimulate the culture for > 48 hrs. 
 In the present investigation, 48 h of electrical stimulation failed to increase OXPHOS 
protein (Figure 2.6C) or respiration in permeabilized myocytes (Figure 2.6D), it did however, 
increase the concentration of lactate in the media at each time point (Figure 2.6A).  Although 
media glucose concentration in the present study (Figure 2.6B) did not differ between the control 
and stimulated groups, the ability of electrical stimulation to increase glycolytic metabolism 
(145) and glucose oxidation appears to be more robust than its ability to increase FAO (107, 131, 
180).  Nikolic et al (131) observed a ~50% increase in glucose oxidation and ~10% increase in 
FAO when measured during the two hours immediately following 24 h of electrical stimulation.  
In this same investigation, glucose uptake was significantly increased at 24 and 48 h in response 
to electrical stimulation whereas oleate uptake remained unchanged.  Furthermore, it was not 
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until after 48 h of electrical stimulation that FAO significantly increased, however, the increase 
remained far below that of glucose (90% vs. 35% increase), indicating a greater reliance on 
glucose oxidation.  In a similar investigation in HSkMC, short-term electrical stimulation 
increased glucose oxidation whereas 24 h of continuous stimulation had no effect on either 
palmitate or oleate oxidation (107).  Short-term aerobic exercise training (7-10 d) in vivo 
decreases the reliance on CHO and increases the reliance on fatty acids (10, 14).  During the 
transition to a greater reliance on fatty acids there is generally also a decrease in muscle lactate 
accumulation.  In the present investigation, media lactate significantly increased at 12 h and 
remained elevated throughout the 48 h stimulation period suggesting the duration of stimulation 
was insufficient to induce a substrate switch characteristic of in vivo short-term training. 
 In culture, human skeletal muscle cells possess fewer mitochondria and derive a greater 
proportion of their energy needs from glycolysis compared to skeletal muscle in vivo (150, 158, 
189).  The addition of lipid to cultured cells increases FAO in HSkMC derived from lean 
individuals (64, 99).  Based on preliminary experiments, we hypothesized that the inclusion of 
lipid may be necessary to promote the use of oxidative metabolism during electrical stimulation.  
In this set of experiments, myotubes were incubated in 100 µM oleate/palmitate for 48 h with or 
without 48 h of continuous electrical stimulation (Figure 2.7A).  A number of observations from 
these experiments can be made 1) electrical stimulation alone can increase FAO and 2) the 
presence of lipid may not facilitate an increase in FAO as electrical stimulation with and without 
the presence of lipid resulted in a similar (~20%) increase in FAO. 
 The ability for continuous electrical stimulation alone to increase FAO is interesting and 
seemingly conflicts with the permeabilized myotube data collected earlier in this investigation in 
which 48 h of continuous stimulation did not increase OXPHOS protein or respiratory capacity 
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(Figures 2.6C & D).  At first glance, these results seem completely at odds, however they may be 
reconciled through differences in methodology.  In the initial continuous electrical stimulation 
data set (Figures 2.6A-D), respiratory capacity was measured utilizing the permeabilized cell 
technique.  In this technique, the cell membrane is permeabilized, all endogenous substrate is 
removed, and oxidizable substrates are sequentially titrated in to test the “capacity” of the 
oxidative phosphorylation system:  endogenous substrates and allosteric regulation have no 
effect on substrate selection.  On the other hand, our data set indicating that electrical stimulation 
increased FAO (Figure 2.7A) was collected in adhered, intact myotubes where endogenous 
substrates are not removed and intracellular regulation may have a profound effect on substrate 
selection.   
 In the permeabilized cell data set (Figures 2.6A-D), lactate concentration in the cell 
media was significantly elevated at each time point (every 12 h), indicating an increased reliance 
on glycolytic, rather than oxidative metabolism.  In this data set, glucose concentration in the 
media was not different between the stimulated and the control cells; therefore it is plausible the 
increased lactate concentration was the result of increased glycogenolysis rather than glucose 
uptake.  An increase in media lactate concentration was also observed in the intact data set (data 
not shown) suggesting glycogenolysis could have potentially lead to a large enough reduction in 
glycogen to promote the increase in FAO observed in the intact cells (Figures 2.7A & B). 
 Alternatively, an increase in FAO may not be due to decreased glycogen stores, and is 
instead a very early adaptation to short-term aerobic training.  In the present investigation, FAO 
was measured approximately 15 hours after the termination of the 48 h stimulation bout.  
Although glycogen content was not measured, it is plausible that glycogen content was 
replenished during this time.  An early response to short-term aerobic training in vivo is an 
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increase in the monocarboxylate transporters (MCT) (70, 71), which are responsible for 
exchanging pyruvate for lactate across the sarcolemma.  In the present investigation, elevated 
media lactate may have been the result of increased MCT expression and exchange of media 
pyruvate for myocyte lactate, rather than increased glycogenolysis.  Although MCT expression 
and increased FAO are likely not directly related, both are markers of an early response to short-
term aerobic training.  Together this would suggest that 48 h of stimulation enhances FAO before 
changes in oxidative capacity appear and occur in a fashion similar to short-term exercise 
training, however, the precise mechanisms underlying the increase in FAO are currently 
unknown. 
 The inability for the presence of lipid to further increase FAO from electrical stimulation 
compared to lipid alone may be reflective of skeletal muscle’s preference for CHO (16) and is in 
agreement with previous findings.  Taube et al (180) incubated HSkMC from lean individuals in 
100 µM palmitate or 100 µM palmitate/adipocyte conditioned media for 24 h, and found that 
when electrical stimulation was simultaneously applied for twenty-four hours intracellular 
triglyceride and FAO remained unchanged, indicating electrical stimulation was unable to rescue 
FAO in vitro.  Data from the present and previous investigations (107, 131, 180) suggest that 
contractile activity initially increases the reliance on CHO and increased FAO may be a 
secondary benefit if the duration of electrical stimulation is of a sufficient length of time (≥ 48 
h).  For the full effects of short-term aerobic training and increased skeletal muscle oxidative 
capacity to be observed, future electrical stimulation investigations in HSkMC should extend the 
stimulation period beyond 48 h.  
Limitations.  There are several limitations in the present investigation and inherent to the in vitro 
model of contractile activity in human primary skeletal muscle cells: 1) The small sample sizes 
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utilized in the present investigation make conclusions from this study difficult to draw and 
comparisons to other investigations difficult to make; 2) HSkMC are extremely unexcitable, 
C2C12 cells are characterized by having an exceptionally low level of excitability and the 
excitability of HSkMC is several orders of magnitude lower than that of C2C12 cells; and 3) 
HSkMC are characterized by a heterogeneous degree of differentiation between and within 
subjects (18, 115), which may contribute to inconsistent results (117).  Myoblasts (126) and 
myotubes are capable of appropriately responding to lipid incubations by upregulating FAO 
regardless of the degree of differentiation or lack thereof.  On the other hand, myotubes must be 
fully differentiated to respond to electrical stimulation, and even then, they may be unresponsive.  
For skeletal muscle myocytes to consistently contract all aspects of excitation contraction 
coupling must be intact including the ability to initiate and propagate an action potential, release 
and sequester calcium, and properly develop and align sarcomeric proteins, aspects of which 
tend to be downregulated in HSkMC (150).  Only the most terminally differentiated myotubes 
are capable of contracting, and oftentimes only represent ~10% of the total culture.  A major 
drawback to myotubes with the degree of differentiation necessary to contract is they tend to 
spontaneously contract without external stimulation (66), resulting in a loss of experimental 
control when both the control group and the stimulated group are contracting.  In this situation, 
inhibiting spontaneous myotube contraction in the control group with tetrodotoxin or another 
paralyzing agent is not an option as this has been shown to alter metabolic enzyme activities (90, 
109, 130). 
 Electrical stimulation has been shown to enhance sarcomeric development and 
contraction (56, 107), however a fine line must be navigated to obtain the desired metabolic 
outcome.  For example, if myotubes are not differentiated to a great enough degree they will not 
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contract and the metabolic response will be blunted.  If myotubes are too differentiated the 
control myotubes will spontaneously contract and both control and stimulated culture plates will 
lose myotubes from cell detachment (69, 147).  Although electrical stimulation has been shown 
to improve sarcomeric development, initiating electrical stimulation too early will result in a 
reduction in myotube striation (112) and a loss of function.  In addition, the currently accepted 
experimental window within which HSkMC are viable is limited to 4-5 d between days 4 and 8 
of differentiation, insufficient time to reach complete maturation.  In rat primary culture, 
Naumann & Pette (128) showed that long term differentiation greater than 10 d was necessary 
for the myotube cultures to express adult form myosin heavy chain and even after 37 d of culture 
adult myosin heavy chain represented ~50% of total myosin indicating that a fully differentiated 
adult state is not reached in vitro.  However, despite the aforementioned functional limitations of 
investigating the metabolic effects in HSkMC, several investigators (107, 131, 180) have been 
able to demonstrate that in vitro electrical stimulation is a viable model for the investigation of 
skeletal muscle contractile activity. 
Summary.  Myotube excitability determines whether a skeletal muscle cell is capable of 
contracting in response to electrical stimulation, which, in turn, is determined by the degree of 
myotube differentiation.  There are an infinite number of electrical stimulation protocols in the 
scientific literature and the vast majority of these protocols are capable of eliciting contractile 
activity, but only in the most differentiated myotubes in culture.  Therefore, the focus of future 
investigations on the effects of electrical stimulation on HSkMC metabolism should target 
factors enhancing myotube maturation (Ultroser G, IGF-1, ECM-gel) to ensure robust responses 
from the cultured cells.  The use of carbon electrodes is warranted due to their superior charge 
transfer characteristics and biocompatibility.  The presence of antibiotic may have a deleterious 
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effect on contractile activity so we would therefore recommend it be excluded from the cell 
media in future electrical stimulation investigations in HSkMC.  In addition, the concentration of 
serum combined with the effects of electrical stimulation promote myoblast proliferation, 
possibly diluting the desired metabolic response and therefore serum should also be eliminated 
or at the very least future experiments should delineate the effects of reductions in serum during 
electrical stimulation.   
 In regards to the stimulation protocol, the results of the present investigation and previous 
literature (107, 131, 180) indicate that continuous electrical stimulation (24-48 h) may be 
superior to intermittent simulation in its ability to increase mitochondrial content and alter 
substrate metabolism in HSkMC.  However, the metabolic outcomes associated with 48 h of 
continuous electrical stimulation in the current investigation were not able to fully replicate 
many of the short-term training adaptations.  Continuous electrical stimulation significantly 
increased lactate concentration at 12 h and remained elevated for the entire stimulation period 
(48 h).  The failure to reduce media lactate concentration, increase OXPHOS protein, or 
oxidative capacity is an indication that our protocol has not yet induced measurable training 
effects at the level of mitochondrial content.  The increase in FAO observed ~15 h after the 48 h 
stimulation period may be a signal of a very early short-term training adaptation.  However, from 
the results contained herein, the HSkMC contractile activity model may be more suited to 
explore the acute effects of exercise (single 3 h bout) rather than short-term training effects.  For 
the short-term training effects to be explored future investigations should look for avenues to 
enhance myotube differentiation and thereby increase the number of myocytes recruited and 
capable of contracting or to increase the training duration from 48 h to ≥ 72 h.  Forty-eight hours 
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of continuous electrical stimulation most closely resembles a single prolonged exercise bout, for 
the effects of short-term training to be observed, the duration of the protocol must be extended. 
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Table 2.1. Range and Reported Values of Selected Electrical Stimulation Parameters from Scientific 
Literature in Cultured Cells 
 Range of Selected Electrical Stimulation Parameters in Cultured Skeletal Muscle 
Hertz     
(Hz) 
0.25 0.5 0.94 1 2 2.5 3 5 6.25 10 25 45 50 100 
Voltage   
(V) 
4 9 10 11.5 14 16 18 20 30 40 50 55 65  
Pulse Width 
(ms) 
0.15 0.2 0.4 1 2 2.5 3 4 10 24     
Time     
(hrs) 
1.5 2 3 4 8 12 24 48       
 
 
 
 
 
 
  
Figure 2.1.  The effect of intermittent 
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Figure 2.2. The effect of intermittent 
primary skeletal muscle cells. 
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Figure 2.3.  Mitochondrial protein
response to intermittent electrical stimulation in C2C12 cells.
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Figure 2.4.  The effect of antibiotic on the ability of various 
protocols to induce mitochondrial biogenesis in C2C12 cells.
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Figure 2.5.  Mitochondrial protein in response to 
human myotubes. 
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Figure 2.6.  The effect of continuous electrical stimulation for 48
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Figure 2.7.  The effect of 48 h of lipid and
oxidation in human primary myotubes
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Supplementary Materials  
 
Video 2.1.  Contracting human skeletal muscle myotubes with electrical pulses at 50 V 10 Hz (4 
x 0.3 ms pulses delivered in 400 ms trains with 3.6 s recovery). 
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Video 2.2. Contracting human skeletal muscle myotubes with electrical pulses at 50 V 10 Hz (4 x 
0.3 ms pulses delivered in 400 ms trains with 3.6 s recovery).
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Video 2.3. Contracting C2C12 myotubes with electrical pulses at 50 V 10 Hz (4 x 0.3 ms pulses 
delivered in 400 ms trains with 3.6 s recovery). 
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Video 2.4. Contracting C2C12 myotubes with electrical pulses at 50 V 10 Hz (4 x 0.3 ms pulses 
delivered in 400 ms trains with 3.6 s recovery). 
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CHAPTER 3:  THE EFFECT OF SUBSTRATE CHALLENGES ON METABOLIC 
FLEXIBILITY IN MYOTUBES DERIVED FROM LEAN AND SEVERELY OBESE 
DONORS 
Abstract 
Objective-Considerable debate exists whether alterations in skeletal muscle mitochondrial 
oxidative capacity and/or content play a causal role in the development of obesity.  In addition, 
the skeletal muscle of severely obese individuals is considered to be metabolically inflexible to 
its nutrient environment.  The purpose of this investigation was to determine whether decrements 
in oxidative capacity and metabolic inflexibility are retained in human skeletal muscle cell 
culture (HSkMC). 
Research design and methods-Muscle biopsies from the vastus lateralis of young lean (22 ± 1 
yr, BMI 22.9 ± 0.7 kg/m2) and severely obese (26 ± 3 yr, BMI 40.7 ± 1.8 kg/m2) men were 
obtained for the culturing of HSkMC.  Measures of respiratory capacity were performed in 
permeabilized and intact primary myotubes along with citrate synthase activity (CS), COX IV 
and OXPHOS protein content, and media measures of glucose and lactate after 24 h incubations 
with BSA (Con), oleate/palmitate (O/P), galactose (Gal), or pyruvate (Pyr).  
Results-No differences in mitochondrial respiratory function or content were observed between 
lean and severely obese subjects with or without the addition of oxidizable substrates.  Both 
groups significantly increased the capacity to respire in response to all three oxidizable substrates 
and increased markers of mitochondrial content to a similar extent.  Both groups also 
demonstrated metabolic flexibility by decreasing reliance on glucose in the presence of 
oxidizable substrates. 
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Conclusions-The results herein suggest that reductions in mitochondrial respiratory 
capacity/content and metabolic inflexibility, if present during obesity, are most likely secondary 
to the initial manifestation of obesity.  
 
Introduction 
 Severe obesity is a condition characterized by a body mass index (BMI) ≥ 40.0 kg/m2, 
expanded adipose stores, and insulin resistance.  Obesity is clearly the result of a chronically 
positive energy balance, however, the degree to which obese individuals accumulate lipid stores 
may also be due to an increased propensity to store rather than oxidize lipid.  The skeletal muscle 
of severely obese individuals has a dampened ability to completely oxidize fatty acids (88, 97) 
and this inability to oxidize fatty acids is associated with a positive lipid balance (5, 182) that 
may promote weight gain.   
 In addition to depressed rates of skeletal muscle fatty acid oxidation (FAO), severely 
obese individuals appear to be resistant to stimuli affecting substrate selection.  For example, the 
imposition of a high fat diet (HFD) increases FAO (10) and the expression of FAO regulating 
genes (22) in lean individuals whereas obese individuals exhibit virtually no change.  The 
inability of the obese individual to increase FAO in the face of a lipid challenge is part of a larger 
phenomenon known as “metabolic inflexibility”.  Originally, David Kelley’s group coined the 
term “metabolic flexibility” when they reported that, in response to insulin stimulation, obese 
skeletal muscle was lacking  “the capacity to switch from predominately lipid oxidation and high 
rates of fatty acid uptake during fasting conditions to the suppression of lipid oxidation and 
increased glucose uptake oxidation, and storage under insulin-stimulated conditions” (96).   
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 The observation that obese skeletal muscle fails to alter fuel selection in the face of a 
lipid challenge is interesting, however, whether the inability to upregulate FAO is a trait of 
skeletal muscle per se or whether this is a secondary consequence of other biological factors 
present in the obese, but not the lean population cannot be determined from in vivo 
measurements.  For example, obese individuals possess substantially larger adipose stores and as 
such the release of free fatty acids (FFA) into circulation is substantially greater (125).  
Elevations in FFA by way of lipid infusion (21) or short-term starvation (83) have been shown to 
induce insulin resistance and reduced metabolic flexibility even in the absence of obesity (21, 
83).  Furthermore, adipose tissue is not an inert storage depot, as it is capable of secreting 
numerous factors known to alter metabolism (134, 136).  It has also become widely accepted that 
in obesity, adipose tissue recruits immune cells and aids in mediating a low-grade inflammatory 
process (4, 34, 132) known to induce insulin resistance.  Any combination of these factors makes 
the in vivo environment in obesity difficult for studying the underlying mechanisms of metabolic 
flexibility.  On the other hand, human primary skeletal muscle cell culture (HSkMC) provides a 
controlled environment for studying skeletal muscle metabolic flexibility as it lacks the 
endocrine environment present in obesity, yet retains the phenotypic traits of the donor skeletal 
muscle (15).   
 The Western diet, which in large part is responsible for the obesity epidemic (168, 174) is 
not only high in fat, but contains excess kilocalories from carbohydrate (CHO) as well (7).  The 
purpose of the current investigation was to compare the effects of lipid or CHO overexposure in 
myotubes cultured from lean and severely obese skeletal muscle.  To that end we incubated 
human primary skeletal muscle cells in either lipid (oleate/palmitate) or CHO (galactose or 
pyruvate) and measured metabolic flexibility in terms of changes in mitochondrial content and 
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respiration in permeabilized or intact cells.  The results contained herein suggest that reductions 
in mitochondrial respiratory capacity/content and metabolic flexibility present in obesity may be 
secondary to the initial manifestation of obesity and the altered regulation of the intracellular and 
systemic environment present in obesity rather than an inherent trait of skeletal muscle. 
 
Methods 
Human subjects.  Healthy, sedentary male subjects (18-40 yrs) that were lean (BMI 22.9 ± 0.7 
kg/m2, n=10) or obese (BMI 40.7 ± 1.8 kg/m2, n=10) were recruited from the faculty and student 
population of East Carolina University.  Exclusion criteria included smoking, the presence of 
diabetes, or heart disease, and taking any medications known to alter metabolism. Subject 
characteristics are described in Table 3.1. The Medical Center Institutional Review Board at East 
Carolina University approved all procedures in this study and all participants signed a written 
informed consent.   
Primary Human Skeletal Muscle Cell Culture (HSkMC).  Following an overnight fast (~12 
hrs), a skeletal muscle biopsy was obtained from the vastus lateralis by the percutaneous needle 
biopsy technique (15, 127).  The isolation and culturing of human primary skeletal muscle cells 
from biopsies was performed as previously described (36).  On day 7 of differentiation, cells 
were incubated for 24  h in differentiation media supplemented with either 0.1% bovine serum 
albumin (BSA) (Control), 100 µM oleate:palmitate (1:1 ratio) bound to 0.1% BSA plus 2 mM 
carnitine (O/P), 10 mM galactose (Gal), or 10 mM pyruvate (Pyr) after which the cells were 
harvested for respirometry experiments.  Separate aliquots of the same passage number were 
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grown and treated similarly, then harvested for the analysis of protein content and citrate 
synthase activity.   
Respirometry experiments: Permeabilized Cells.  Myotubes were permeabilized for respiration 
experiments as previously described (106).  Myotubes were washed with PBS and lifted from 
culture flasks with 0.05% trypsin EDTA.  This reaction was neutralized by adding 10% FBS to 
the cell suspension and centrifuged for 10min at 1000 rpm at room temperature.  The cell pellet 
was then resuspended in growth media, counted using a hemocytometer, centrifuged again for 10 
min, and re-suspended in room temperature respiration buffer (130 mM sucrose, 60 mM 
potassium gluconate, 1 mM EGTA, 3 mM magnesium chloride, 10 mM potassium phosphate, 20 
mM HEPES, 0.1% BSA; pH 7.4).  The cells were then treated with 3 µg/106 cells/ml digitonin 
(i.e., a mild, cholesterol-specific detergent) for 5 min at 37° C on an orbital shaker.  Following 
permeabilization, myotubes were washed by centrifugation at 1000 rpm for 5 min to remove 
endogenous substrates.  The cells were then resuspended in respiration buffer at a concentration 
of (1.5 × 106cells per 2ml) and loaded into a respiration chamber (Oroboros Oxygraph-2K, 
Oroboros Instruments Corp., Innsbruck, Austria). To avoid potential limitations due to oxygen 
availability, all experiments were conducted after the oxygraph chamber was hyperoxygenated to 
an oxygen concentration of ~300 nmol/ml.  Side-by-side experiments under control, 
oleate/palmitate, galactose, and pyruvate conditions were performed on cells from each subject.  
Oxygen consumption was normalized to total protein (BCA assay; Pierce Biotechnology, 
Rockford, IL). 
For the permeabilization experiments, substrate concentrations were chosen based upon 
the methods of Pesta & Gnaiger (138) known to elicit maximal rates of respiration in human 
cells.  The concentration and sequence of substrate titrations are found in Table 3.2. 
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Respirometry experiments: Live Cell.  Myotubes were harvested as described above and 
resuspended in fresh differentiation media identical to the media the cells were originally 
incubated in for 24 h (BSA, O/P, Gal, or Pyr) at a concentration of (2.0 × 106cells per 2ml) and 
loaded into the respiration chamber (Oroboros Oxygraph-2K, Oroboros Instruments Corp., 
Innsbruck, Austria).  Oxygen consumption was measured during basal respiration and after the 
addition of 5 µM FCCP.  Data was normalized to cell count. 
Protein content.  Cells were harvested in 100 µl ice-cold lysis buffer (50 mM HEPES [pH 7.4], 
10 mM EDTA, 100 mM NaF, 12 mM Na pyrophosphate, 1% Triton X-100) supplemented with 
protease and phosphatase inhibitors (Sigma-Aldrich).  Samples were sonicated, rotated end-over-
end at 4⁰ C for 1 h, and centrifuged at 20,000 g for 30 min at 4⁰ C.  Protein concentrations were 
determined using the bicinchoninic acid (BCA) assay (Pierce Biotechnology, Rockford, IL). 
Twenty micrograms of protein were separated by SDS-PAGE and electrotransferred to 
polyvinylidene fluoride (PVDF) membranes (Millipore, Billerica, MA) and probed overnight for 
cytochrome c oxidase (COX) IV (1:1000; Cell Signaling, Beverly, MA) and with a cocktail 
containing antibodies against the following proteins (1:1000): Complex I subunit NDUFB8, 
Complex II subunit 30kDa, Complex III subunit Core 2, Complex IV subunit II, and ATP 
synthase subunit alpha (MitoSciences, Eugene, OR).  Membranes were incubated for 1 h at room 
temperature with the corresponding secondary antibody and the immunoreactive proteins were 
detected using enhanced chemiluminescence (ChemiDoc XRS+ Imaging System, BioRad 
Laboratories, Inc., Hercules, CA).  Samples were normalized to a crude cell sample on each gel 
to normalize for blotting efficiency across gels.   
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Citrate Synthase Activity.  Citrate synthase activity was determined using a standard assay kit 
(Sigma CS0720, St. Louis, MO), which colorimetrically measures the reaction rate between 
acetyl coenzyme A and oxaloacetic acid. 
Glucose and Lactate.  Media was collected after 24 h incubations and immediately frozen at -
80° C for the subsequent determination of glucose and lactate.  Glucose and lactate were 
determined by oxidation reaction (YSI model 2300 Stat Plus; Yellow Springs Instruments, 
Yellow Springs, OH).  Glucose disappearance was calculated as the glucose concentration at the 
end of the incubation period subtracted from the concentration in the stock differentiation media.  
Measures of glucose disappearance and media lactate were then normalized to cell count. 
Statistical Analyses.  Data are presented as mean ± SEM.  Statistical analyses were performed 
using t-tests for subject characteristics, 1-way ANOVA with Student-Newman-Keuls or 2-way 
repeated measures ANOVA with Bonferroni post hoc test where appropriate for the analysis of 
significance among groups.  The level of significance was set at P < 0.05. 
 
Results 
Subject characteristics.  Subject characteristics are presented in Table 3.1.  By design, the obese 
individuals were heavier and had a significantly higher body mass index (BMI) (22.9 ± 0.8 
kg/m2, 40.7 ± 1.8 kg/m2) than their lean counterparts (P < 0.0001).  Fasting blood glucose was 
similar between groups; however, corresponding insulin values were significantly elevated in the 
obese subjects (P = 0.001).  As, expected, HOMA-IR values were also significantly elevated in 
obese subjects, suggesting an insulin resistant phenotype (P = 0.004).  
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Obesity does not impact mitochondrial content or respiratory capacity within primary human 
myotubes.  To assess whether mitochondrial content in myotubes from lean and obese differed, 
we measured citrate synthase activity (CS), COX IV protein, and proteins of the OXPHOS 
cocktail (MitoSciences).  These measures of mitochondrial content were selected as they 
represent two distinct compartments, the TCA cycle and the electron transport chain.  CS, COX 
IV, or OXPHOS proteins did not differ between lean and obese under control conditions (Figures 
1A-B). 
To determine whether mitochondrial respiratory capacity differed in skeletal muscle cells 
prepared from lean and obese we assessed respiration in digitonin-permeabilized primary human 
myotubes.  In order to assess the capacity for electron transfer within the entire system, a 
comprehensive protocol was designed in which saturating concentrations of substrates directed at 
complex-I, complex-II and β-oxidation were added in the presence of ADP (138) (Table 3.2).  
Utilizing this protocol, respiratory capacity was not different in myotubes from lean and obese 
(Figure 3.1C).  Although not significant, the response to succinate (P = 0.23) and FCCP (P = 
0.31) tended to be higher in lean cells, suggesting a possible divergent rate of electron transport 
at the level of complex-II between groups.  To address this possibility, succinate supported 
respiration was assayed in the presence of rotenone under basal (S4), maximal-ADP (S3) and 
uncoupled (FCCP) conditions (Figure 3.1D).  Once again, no significant differences were 
observed between lean and obese myotubes.  
Acute exposure to oxidizable substrates increases mitochondrial content in lean and obese to a 
similar extent.  There were no differences in the absolute amount of OXPHOS, COX IV protein, 
or CS activity between lean and obese after 24 h substrate incubations (data not shown).  There 
were, however, differences in the lean/obese responses to the incubations.  Complex I protein 
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increased in both groups in response to O/P (Figure 3.2A) and galactose (Figure 3.2B) (all P < 
0.001) in contrast to pyruvate where the lean increased (P = 0.01) but the obese did not (P = 
0.17) (Figure 3.2C).  Complex II and III protein increased in the lean group in response to O/P 
(both P = 0.01) and galactose (both P < 0.05) but neither changed in the obese group (Figures 
3.2A-B).  Both groups tended to increase CS in response to O/P (lean P = 0.08, obese P = 0.04) 
(Figure 3.2A) and galactose (both P < 0.05) (Figure 3.2B).  Pyruvate incubation did not change 
Complex II or III protein or citrate synthase in either group (Figure 3.2C).  
Acute exposure to oxidizable substrates increases the capacity to respire in lean and obese to a 
similar extent.  There was a main effect for all three substrates (O/P, Gal, Pyr) to increase 
palmitoyl-carnitine malate supported respiration in the presence of ADP (PCM3) (P < 0.01) and 
FCCP-stimulated respiration (P < 0.01) with no effect of group (Figures 3.3A-C).  To 
demonstrate the collective effect of acute oxidizable substrate incubations during our respiratory 
protocol (Table 3.2), lean and obese groups were pooled (Figure 3.3D).  Incubation with O/P, 
Gal, or Pyr significantly increased palmitoyl-carnitine malate (ADP), glutamate (G), succinate 
(S), and uncoupled respiration (FCCP) in the presence of ADP (P < 0.01).   
Myotubes from lean and obese individuals increased the capacity to respire to the same 
extent when challenged with an acute 24 h exposure to oxidizable substrates (O/P, Gal, Pyr).  We 
next sought to determine whether this increased capacity to respire translated into functional, 
real-time increases in oxygen consumption.  In this set of experiments we utilized intact, rather 
than permeabilized myotubes.  Compared to control conditions, basal respiration increased after 
Pyr incubation (P < 0.05).  Respiration also tended to be elevated after O/P and Gal incubations, 
however, the difference did not reach significance (Figure 3.4A).  The addition of FCCP 
increased respiration under all conditions, but was significantly elevated above FCCP control 
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when challenged with O/P, Gal, or Pyr (P < 0.05) (Figure 3.4A).  Basal (P = 0.09) and FCCP-
induced respiration (P = 0.06) tended to be higher in the cells prepared from obese subjects under 
control conditions when only glucose was available (Figure 3.4B). 
To confirm that myotubes from lean and obese individuals increased their reliance on 
oxidative metabolism in response to lipid and CHO challenges, media lactate concentration and 
glucose disappearance were measured.  As expected, glucose disappearance (Figures 3.5 A-B) 
and media lactate concentration (Figures 3.5 C-D) were lower for each substrate tested compared 
to control conditions.  Although significance was not achieved, obese cells tended to utilize less 
glucose (Figures 3.5 A-B) and produce less lactate (Figures 3.5 C-D) under all conditions 
compared to lean myotubes, suggesting an increased reliance on oxidative metabolism in the 
obese cells. 
   
Discussion 
 In the present study, measures of OXPHOS protein content, citrate synthase activity, and 
cellular respiration were not different between myotubes derived from lean and obese subjects.  
Furthermore, metabolic flexibility as determined by the ability to adapt to oxidizable substrates 
was not substantially different between groups.  Collectively, the present findings do not support 
a role for inherent detriments in mitochondrial oxidative capacity (often referred to as 
“mitochondrial dysfunction”) as a primary “cause” of obesity.  
 Mitochondrial content (85, 95, 97, 152) and FAO (14, 85, 88, 97, 183) tend to be reduced 
in the skeletal muscle of obese individuals.  However, from these in vivo studies it is difficult to 
determine whether obesity precedes decrements in FAO or whether decrements in FAO precede 
obesity.  Obesity may take years to develop and is characterized by numerous endocrine 
  
 
60 
abnormalities that are likely the result of lifestyle choices.  HSkMC is thought to retain the 
underlying phenotype of the parent donor thereby providing a potential avenue to study obesity 
in individuals prone to obesity before it develops.  For that reason, human primary skeletal 
muscle cell culture (HSkMC) was utilized in this study.  Data from human primary myotubes in 
the field of obesity research have thus far been contradictory.  In a previous investigation, human 
primary cells isolated from severely obese women (BMI = 45.3 ± 1.4) displayed significant 
reductions in mtDNA (27%), COXIV protein (35%), and TFAM protein (43%) (36).  In contrast, 
HSkMC isolated from severely obese men (BMI = 39.0 ± 2.0) displayed no decrease in mtDNA, 
COXIV protein, or CS (23), findings that are in agreement with the current investigation  
(Figures 3.1A-B).  The discrepancies in the cell culture studies may originate from differences in 
gender and adiposity although the exact mechanisms are not apparent.   
 In the current investigation under control conditions respiratory capacity was similar 
between lean and obese (Figures 3.1C-D), which coincides with similar mitochondrial content 
between groups (Figures 3.1A-B).  In human primary skeletal muscle myotubes, Boyle et al (23) 
also reported no difference in respiratory capacity in lean and severely obese individuals.  
Collectively, these data tend to suggest that skeletal muscle oxidative capacity in lean and obese 
individuals may not be inherently different in skeletal muscle myotubes when independent of 
metabolic influences in vivo.   
 The response to a metabolic challenge, such as an increase in lipid availability, may be a 
stronger determinant in the development of obesity than initial oxidative capacity.  In response to 
a high fat diet, lean individuals rapidly increase fatty acid oxidation to match nutrient availability 
whereas obese individuals do not (10, 182).  Boyle et al (23) extended these findings to human 
primary skeletal myotubes by demonstrating that, when exposed to a 24 h lipid challenge, 
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myotubes cultured from lean individuals upregulate the capacity to oxidize fatty acids whereas 
their obese counterparts do not respond.  The ability of the lean group to appropriately match 
nutrient oxidation with nutrient availability is known as metabolic flexibility (96).  To expand 
upon the findings of Boyle et al (23) and to investigate the effects of other sources of excess 
kilocalories in the Western diet, we sought to determine whether skeletal muscle cells from 
severely obese individuals were also unresponsive (metabolically inflexible) when challenged 
with excess CHO in the form of either galactose or pyruvate. 
In contrast to skeletal muscle tissue, which relies almost exclusively on oxidative 
phosphorylation to meets its energetic needs in the basal state, cells grown in culture derive a 
considerable amount of ATP via glycolysis (150).  Replacing glucose with galactose in the 
culture media has previously been shown to induce widespread alterations in mitochondrial 
content, morphology and oxidative capacity, presumably as a consequence of increased reliance 
on oxidative phosphorylation within the galactose grown cells (2).  In addition, 
supraphysiological pyruvate incubations have been shown to increase mitochondrial content in 
immortalized cell lines (143, 204).  In order to determine any potential differences in adaptability 
between lean and obese cells, myotubes were incubated for 24 hours in the presence of three 
different oxidizable substrates (oleate/palmitate, galactose, pyruvate).   
 Interestingly, metabolic flexibility was retained in HSkMC isolated from severely obese 
individuals in response to not only excess CHO but lipid as well: CS and OXPHOS protein 
(Figures 3.2A-C) and permeabilized respiration (Figures 3.3A-C) increased and glucose 
utilization decreased (Figures 3.5A-B) in response to lipid or CHO incubations in both the lean 
and the severely obese groups.  These results are in opposition to those reported by Boyle et al 
(23), in which myotubes from severely obese individuals failed to increase the capacity to 
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oxidize fatty acids in response to a 24 h lipid incubation.  The contrast in outcomes between the 
previous and present investigation are likely the result of differences in methodologies as each 
study utilized an established, yet different permeabilization protocol, (105) and (106) 
respectively.  Boyle et al (23) carried out cell permeabilization directly in the oxygraph chamber 
(we permeabilized prior to placing the cells in the oxygraph) and utilized digitonin 
concentrations 2-3 fold higher and substrate concentrations 2-3 fold lower than those reported 
herein.  We also hyperoxygenated the oxygraph chamber whereas Boyle et al did not.  The 
robust ADP response in all conditions combined with the absence of a cytochrome C response 
makes us confident that myotubes in the current investigation were appropriately permeabilized.  
The exact cause of the difference in results between studies remains uncertain. 
 Several investigators have demonstrated that metabolic flexibility is absent in myotubes 
derived from obese individuals when exposed to lipid (37, 99), or grown in galactose (2), 
however the obese subjects in these previous studies were also diabetic.  Metabolic disease tends 
to operate on a continuum with lean individuals being the most healthy, diabetics the least, and 
obese falling somewhere in-between.  In studies investigating the response to metabolic stimuli 
(lipid, galactose, acetate, insulin) in myotubes derived from lean, obese, and diabetic individuals, 
lean and obese groups tend to respond in a similar fashion, whereas the diabetic response is 
severely inhibited (2, 38, 61-63, 133, 200).  It should be noted that in the majority of these 
investigations, the obese group is not severely obese, however, the findings in the current 
investigation suggest that metabolic flexibility in the severely obese group remains intact. 
 Although the present findings demonstrate the capacity to respire and the rate of oxygen 
consumption do not differ between groups with the addition of oxidizable substrates, these 
measures give no indication of whether glucose or fatty acids were utilized to meet those oxygen 
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demands.  Therefore, some degree of metabolic inflexibility cannot be ruled out.  In the present 
study, the obese subjects were significantly more insulin resistant as indicated by an increased 
HOMA value (Table 3.1).  Galgani et al (57) has attributed the in vivo metabolic inflexibility in 
obese and diabetic individuals described by Kelley et al (96) primarily to insulin resistance, as 
normal metabolic flexibility is exhibited when metabolic flexibility is normalized to glucose 
uptake.  Although no insulin was utilized in the present investigation there were differences in 
glucose metabolism between groups.  The obese group took up less glucose and produced less 
lactate (Figures 3.5A & C), yet consumed more oxygen during basal conditions (Figure 3.4A).  
Exposure to oxidizable substrates did not further enhance basal oxygen consumption in the 
severely obese group whereas respiration tended to increase in the lean group (Figure 3.4A).  
These findings may suggest that under basal conditions the lean group was metabolically 
flexible, whereas the obese was not.  However, when energy demand was increased through the 
addition of FCCP to the oxygraph chamber, the obese group increased oxygen consumption well 
beyond that of glucose only supported respiration in the presence of lipid, galactose, and 
pyruvate, demonstrating metabolic flexibility remained intact.  
 Is metabolic flexibility an inherited or a developed trait?  Gaster et al (61) previously 
demonstrated that metabolic flexibility remains intact in myotubes from obese and diabetic 
groups in response to fatty acids and insulin.  Although the differences in the responses between 
groups in the Gaster et al (61) investigation were not significantly different, there were clear 
stepwise reductions in the magnitude of the responses from lean to obese to diabetic.  The obese 
subjects in the current investigation were young (26 ± 3 yr), healthy, and likely not far into the 
progression of metabolic disease, which may have contributed to their ability to remain 
metabolically flexible.  Following standardized weight loss protocols, post-diabetic individuals 
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have been shown to improve in vivo insulin sensitivity similar to their lean counterparts (2) or no 
longer exhibited diabetes by measures of fasting blood glucose and hemoglobin A1C (38).  
However, in each investigation, impairments in mitochondrial biogenesis (38) or oxygen 
consumption rate (2) were still apparent in myotubes established from muscle biopsies after 
weight loss.  It is currently unknown whether metabolic flexibility is restored after weight loss in 
severely obese individuals that are older and further into the disease progression.  Future 
investigations should determine the longitudinal effects of weight loss, exercise, and dietary 
macronutrient variations on the effect of HSkMC substrate selection and metabolism. 
Conclusion.  The results of the current investigation do not support a causal role for reductions 
in oxidative capacity to precede the obese phenotype.  There were no substantial differences in 
citrate synthase activity, COX IV protein, or OXPHOS protein in myotubes derived from lean 
and obese individuals at baseline or in response to an acute exposure to oxidizable substrates nor 
were there any differences noted in respiratory capacity measured in permeabilized myofibers or 
in intact cells.  Incubation of myotubes with oxidizable substrates decreased glucose utilization 
and favored a more oxidative phenotype in lean and severely obese, indicating metabolic 
flexibility was intact in both groups.  Taken together these results suggest that the decrements in 
oxidative capacity associated with obesity are likely secondary to the effects of obesity, such as 
expanded adipose stores, the inability to regulate free fatty acids during insulin stimulation, 
insulin resistance, and physical inactivity, and not a defect inherent to skeletal muscle. 
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Table 3.1. Characteristics of the study groups. 
 Lean  
 (n = 10) 
Obese 
(n = 10) 
Age [yr] 22 ± 1 26 ± 3 
BMI [kg/m2] 22.9 ± 0.8 40.7 ± 1.8* 
Body fat [%] 21.6 ± 2.2 38.9 ± 1.4* 
Fasting plasma glucose 
[mg/dL] 
84.5 ± 2.7 86.8 ± 2.7 
Fasting plasma insulin 
[µU/mL] 
3.5 ± 0.8 14.5 ± 1.9* 
HOMA-IR   [(mM*mU/L)2] 0.8 ± 0.2 3.1 ± 0.4* 
 
Data are mean ± SEM. BMI, body mass index, * Different from lean (P < 0.05) 
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Table 3.2. Respirometry protocol for permeabilized cells 
 
Step Substrate Notation Concentration 
1 Respiration Buffer  3 µg/106 cells/ml 
2 Palmitoyl carnitine PC 25 µmol l-1 
3 Malate M 2 mmol l-1 
4 ADP D 4 mmol l-1 
5 Cytochrome C Cyt C 10 µmol l-1 
6 Glutamate G 10 mmol l-1 
7 Succinate S 10 mmol l-1 
8 FCCP FCCP 2 µmol l-1 
  
Figure 3.1. Mitochondrial content and respiratory capacity in primary human myotubes from 
lean and obese individuals under control conditions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mitochondrial content and oxygen consumption was assessed in human primary myotubes 
prepared from vastus lateralis muscle of lean and obese subjects (
activity, expressed as µmol citrate/mg protein/min. (
OXPHOS (MitoSciences) and COX IV protein 
consumption in response to PC –
Cyto C – cytochrome C [10µM]; G 
Carbonyl cyanide p trifluoro methoxyphenylhydrazone [2
the presence of succinate [10mM] plus rotenone [1
and uncoupled (FCCP) conditions. 
10 (C), n = 4-5 (D)  
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A-D). (A) Citrate synthase 
B) Western blot analysis of mitochondrial 
prepared from cell lysate. (C) Rates of O
 palmitoyl carnitine [25µM]; M - malate [2mM]; ADP [4mM]; 
– glutamate [10mM]; S – succinate [10mM]; FCCP 
µM].  (D) Rates of O2 
µM], under basal (S4), ADP-stimulated (S
Data represent mean ± SEM; n = 10 (A), n = 9
2 
- 
consumption in 
3), 
-10 (B), n = 9-
  
Figure 3.2. Fold change in citrate synthase activity (CS), COX IV, and 
primary human myotubes from lean and obese individuals.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mitochondrial content was determined in fully differentiated myotubes that were incubated for 
24 hours in the presence of 0.1% BSA (Control), 100 
(B) or 10 mM pyruvate (C), all of which were added directly to the di
OXPHOS (Complexes I, II, III, and V) protein, COX IV protein, and citrate synthase activity 
(CS) were determined in myotubes from lean and obese and expressed as fold change from 
respective BSA control.  Data are fold change normalized
n = 9-10 (A-C). *Different from BSA control (P < 0.05).  
(P < 0.05). 
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OXPHOS protein in 
 
µM oleate/palmitate (A), 10 mM galactose 
fferentiation media. 
 to control and represent mean ± SEM; 
#Different from corresponding obese 
  
Figure 3.3.  Respiratory capacity in human primary 
response to substrate challenges. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fully differentiated myotubes were incubated for 24 hours in the presence of either 100 
oleate/palmitate (O/P) (A), 10 mM galactose (Gal) 
which were added directly to the differentiation media.  Following this 24
myotubes were harvested, permeabilized and oxygen consumption was assessed (
O2 consumption in response to PC 
[4mM] (PCM3) Cyto C – cytochrome C [10
FCCP - Carbonyl cyanide p trifluoro methoxyphenylhydrazone [2
obese subjects were pooled to illustrate the effects o
± SEM; n = 9-10 (A-C), n = 19 (
of group.  #Different from corresponding control condition (P < 0.01).
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myotubes from lean and obese individuals in 
 
(B), or 10 mM pyruvate (Pyr) 
-hour incubation, 
– palmitoyl carnitine [25µM]; M - malate [2mM]; ADP 
µM]; G – glutamate [10mM]; S – succinate [10mM]; 
µM].  (D) Data from lean and 
f each substrate tested.  Data represent mean 
D).  *Main effect of treatment (P < 0.01).  There was no effect 
 
µM 
(C), all of 
A-D).  Rates of 
  
Figure 3.4. Basal and FCCP-stimulated respiration within
 
 
 
 
 
 
 
 
Basal and FCCP [5µM]-stimulated respiration was assessed in intact primary human myotubes, 
following a 24-hour incubation with 100 
10 mM pyruvate (Pyr) (A-B).  Assays were performed in differentiation media alone (Con) or in 
differentiation media identical to the media the cells were originally incubated in for 24 h (O/P, 
Gal, or Pyr) (A) Pooled data from lean and 
represent mean ± SEM; n = 14-16 (
condition (P < 0.05). #Different from corresponding control
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 intact primary human myotubes.
µM oleate/palmitate (O/P), 10 mM galactose (Gal), or 
obese subjects.  (B) Lean and obese responses.  Data 
A), n = 7-8 (B).  *Different from corresponding basal control 
-FCCP condition (P < 0.05).
 
 
  
Figure 3.5.  Glucose disappearance
challenges in human primary myotubes
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fully differentiated myotubes were incubated for 24 hours in the presence of 
oleate/palmitate (O/P), 10 mM galactose (Gal), or 10 mM pyruvate (Pyr), all of which were 
added directly to the differentiation media.  
incubation period in lean and obese.  
obese subjects.  (C) Lactate concentration of the media after
lean and obese.  (D) Pooled data 
Data represent mean ± SEM; n = 7
control condition (P < 0.05). 
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 and media lactate concentration in response to 24 h substrate 
 from lean and obese individuals. 
 
 
either 100 
(A) Glucose disappearance during the 24
(B) Pooled data of glucose disappearance from lean and 
 the 24-hour incubation period
of media lactate concentration from lean and obese subjects.  
-8 (A, C), n = 14-16 (B, D).  *Different from corresponding 
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CHAPTER 4: INTEGRATED DISCUSSION 
 In the past 40 years the prevalence of adult obesity in the United States has increased 
dramatically from 11.9% to 35.5% in men and from 16.6% to 35.8% in women (53, 54).  
Coinciding with the increased prevalence of obesity were the findings that an elevated whole 
body respiratory quotient (RQ) was predictive of future weight gain (211) and that skeletal 
muscle RQ was elevated in obese individuals (94).  The increased reliance on carbohydrate 
(CHO) in obese individuals has led some investigators to question whether the increase in CHO 
oxidation was, in part, compensation for an inability to oxidize fatty acids (82).  Twenty-five 
years of investigation of fatty acid metabolism by our laboratory has revealed depressed fatty 
acid oxidation in the skeletal muscle of obese individuals utilizing numerous methodologies: 
intact muscle strips (88), muscle homogenates from vastus lateralis biopsies (97), in vivo tracers 
(183), and in human primary skeletal muscle cell culture (11, 36, 87).  From these studies we 
have hypothesized that the inability to oxidize fatty acids in obese individuals may have 
contributed to their positive lipid balance and weight gain (52, 149).  Numerous investigators 
have shown that weight loss drastically improves metabolic health but has little effect on the 
ability of previously obese individuals to oxidize fatty acids (5, 14, 94, 159, 183), leaving them 
prone to weight regain (5, 55, 118, 119, 191).  Our laboratory has also shown that 10 consecutive 
days of aerobic training rescues fatty acid oxidation (FAO) by increasing skeletal muscle FAO in 
lean, obese, and previously obese individuals to the same extent (14), making exercise one of the 
few interventions to correct the impaired ability to oxidize fatty acids in the obese individual.  
Furthermore, our lab (10, 22, 23) and others (5, 182) have found that obese individuals 
demonstrate an impaired response to upregulate FAO in the face of a lipid challenge.  The 
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inability to upregulate FAO in response to increased dietary fat may result in a positive lipid 
balance and leave the obese individual vulnerable to future weight gain.   
 The current investigation had two primary aims.  Aim 1 was to develop an in vitro model 
of short-term exercise training (contractile activity) to determine the mechanisms responsible for 
normalizing FAO in obese and previously obese individuals.  The second aim of this 
investigation was to determine whether the inability of the skeletal muscle cells from obese 
individuals to respond to increases in dietary lipid was unique to dietary lipid or whether the 
inability to switch between substrates encompassed other oxidizable substrates as well. 
Adaptations to Short-Term Exercise Training In Vivo 
 Aerobic training increases the reliance on fatty acids during exercise (78, 120) and in 
some cases at rest (159).  Cross sectional studies have demonstrated that aerobically fit 
individuals possess a high skeletal muscle oxidative capacity and increased rates of fatty acid 
oxidation during submaximal exercise (100, 186, 193).  The evidence from cross sectional and 
aerobic training studies have lead to the conclusion that enhancing skeletal muscle oxidative 
capacity will increase the reliance on fatty acids.  However, the increase in FAO during short-
term exercise training (one bout to ~10 d) does not always coincide with increased oxidative 
capacity, thus disconnecting this relationship.  
 Untrained individuals are highly reliant on carbohydrate oxidation during exercise 
training.  For example, in an untrained individual, a single acute bout of aerobic exercise for 60 
min at 62% VO2max decreases muscle glycogen content by 73.2% and increases muscle lactate 
by 7.1 fold (73).  By comparison, four weeks of aerobic training in these same individuals 
resulted in muscle glycogen content reductions of only 20.4% and lactate increases of only 2.8 
fold upon the completion of 60 min of exercise at the same absolute intensity (73).  One of the 
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earliest adaptations to aerobic exercise training is a decreased reliance on CHO and a decrease in 
lactate production; as few as three consecutive days of exercise training has been shown to 
dramatically decrease muscle lactate accumulation (70).  Although data for the ability of three 
consecutive days of aerobic exercise to increase FAO is lacking, FAO has been shown to 
increase in muscle homogenates from the vastus lateralis of previously untrained individuals 
with as little as seven days of aerobic training (10).   
 A caveat to the switch in substrate utilization from predominately CHO to increased fatty 
acid utilization during short-term aerobic exercise training is there is often no change in skeletal 
muscle oxidative capacity during this training period, thus disconnecting the relationship 
between skeletal muscle oxidative capacity and substrate utilization.  Short-term training studies 
consisting of 3 d (70), 5 d (141), 5-7 d (72), and 10-12 d (74) of consecutive training have shown 
that the activities of succinate dehydrogenase (SDH), citrate synthase (CS), and β-hydroxy-acetyl 
coenzyme A dehydrogenase (β-HAD) have not yet increased whereas longer training durations 
of 14 d (176) and 31 d (141) robustly increase these same markers of mitochondrial content in 
skeletal muscle.  It should be noted that some short-term training studies of 6-10 d have 
increased skeletal muscle mitochondrial content (32, 169), however this is not always the case.  
In a recent study in our own laboratory, seven consecutive days of aerobic training increased 
FAO in muscle homogenates and CS but not OXPHOS and COX IV protein or β-HAD activity 
(10).   
 It appears that seven consecutive days of aerobic training may be at or around the 
crossroads where the reliance on fatty acids increases before changes in mitochondrial content 
comprehensively occur.  The goal of the present investigation was to establish an in vitro 
contractile activity model in human primary skeletal muscle cells capable of mimicking some of 
  
 
76 
the adaptations to short-term exercise training such as increasing the reliance on FAO and at the 
same time increasing markers of mitochondrial content and capacity.  To achieve these 
objectives, two types of electrical stimulation protocols, intermittent (3 h/d 2-4 d) and continuous 
(48 consecutive h), were employed in this investigation.  
Intermittent (3 h/d 2-4 d) Electrical Stimulation 
 The main finding of the intermittent electrical stimulation investigation was that short-
term (3 h/d, 2-4 d) electrical stimulation of human primary skeletal muscle cells (HSkMC) was 
ineffective in mimicking the in vivo effect of short-term exercise training due to the model’s 
inability to consistently increase FAO (Figures 2.1A-D) or markers of mitochondrial content 
(Figure 2.2A).  Although the small sample sizes from individual experiments prevent definite 
conclusions from being drawn, this investigation utilized more than five electrical stimulation 
protocols (28, 42, 131, 145, 188) and well over 100 trials in HSkMC and C2C12 cells and was 
unable to demonstrate a consistent increase in either mitochondrial content or FAO.  The videos 
that we (Supplementary Materials; Videos 2.1-2.4) and others (107, 117, 121, 129, 131, 148) 
have produced demonstrate the excitability of cultured cells under electrical stimulation pacing.  
There are also a number of investigators who have demonstrated that acute stimulation results in 
calcium cycling (48, 101, 103, 117, 190) as well as increases in the mRNA of transcriptional (28, 
131, 165, 188), and oxidative genes (28, 131, 188).  However, to date, Hood and colleagues are 
the sole investigators to observe functional changes in transcription factor and oxidative protein, 
or oxygen consumption in response to intermittent electrical stimulation (89, 188).  In their first 
investigation Irrcher et al (89) observed an increase in transcription factor and coactivator protein 
(TFAM, PGC-1α, and NRF-1) but not mitochondrial protein (Cty C) after 4 days of intermittent 
electrical stimulation in C2C12 cells.  From these data it is tempting to speculate the duration of 
  
 
77 
electrical stimulation was great enough to increase transcription factor protein, yet, insufficient to 
translate into functional oxidative protein.  However, in a later investigation using a similar but 
less intense 4-day intermittent protocol (9 V vs. 55 V), Uguccioni & Hood (188) observed 
increased TFAM and COX IV protein as well as COX activity and intact cell respiration as 
measured by a Clarke electrode, indicating mitochondrial protein content was enhanced.  In the 
current investigation, the electrical stimulation parameters utilized by Hood and colleagues (89, 
188) resulted in either no increase in COX IV protein (C2C12, HSkMC) (Figures 2.2A, 2.3A, & 
2.4A) or cell death (HSkMC).  Although the pulse generator and stimulator plates used in the 
previous studies and current investigation are different the exact cause of the experimental 
differences remains unclear. 
 One factor that may have prevented the intermittent electrical stimulation protocols from 
facilitating any appreciate changes in our desired metabolic outcomes in HSkMC is their relative 
lack of excitability.  The excitability of cultured cells is greatest in rat and mouse primary cells 
and C2C12 cells possess  “exceptionally low excitability” (41).  Our observations have shown 
the excitability of HSkMC to be several orders of magnitude less excitable than C2C12 cells 
(Supplementary Materials; Videos 2.1-2.4).  We felt the general lack of excitability in HSkMC 
combined with our desire to observe a training effect may have necessitated longer periods (48 
h) of electrical stimulation and a greater number of myotube contractions before changes in 
oxidative capacity were to occur.    
Continuous (48 h) Electrical Stimulation 
 In the present study, continuous electrical stimulation for 48 h was found to resemble a 
mixture of adaptations similar to both a) short-term exercise training and b) a single acute 
prolonged exercise bout.  In short-term in vivo exercise training, daily, consecutive training bouts 
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result in transient adaptations, the accumulation of which increases oxidative capacity over the 
course of several weeks.  In turn, there is a decreased reliance on CHO, glycogen sparing, 
decreased lactate accumulation, and increased FAO during each successive training bout (70, 73, 
176).  The adaptations in substrate selection, namely decreased lactate accumulation and 
increased FAO, are believed to be the direct result of an increased oxidative capacity.  On the 
other hand, an increase in FAO during a single acute prolonged exercise bout is primarily the 
result of glycogen depletion, not an increase in oxidative capacity.  
 In the present investigation, 48 h of electrical stimulation in vitro did not increase 
OXPHOS protein or respiratory capacity (Figures 2.6C & D).  These observations suggest that 
48 h of electrical stimulation in culture is not comparable to the very minimum amount (6-10 d) 
of in vivo endurance training necessary to increase skeletal muscle oxidative capacity and is 
probably more similar to a single acute bout of prolonged exercise, which would not be expected 
to increase oxidative capacity.    
 Another very early adaptation in response to short-term in vivo training is a reduction in 
muscle and blood lactate accumulation in subsequent training bouts (70).  In the present 
investigation, media lactate concentration increased at 12 h of electrical stimulation and 
remained elevated throughout the 48 h stimulation period despite fresh media changes every 12 h 
(Figure 2.6A).  The failure of media lactate not to decrease during the latter stages of the 48 h 
stimulation period suggests the myotubes remained reliant on glycolysis, and although increased 
media lactate is indicative of a stimulation effect, the pattern of lactate accumulation in the media 
is more indicative of a single acute bout of exercise than it is of the cumulate effects of short-
term exercise training. 
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 In the present investigation, forty-eight hours of continuous stimulation was able to 
increase FAO (Figure 2.7A).  Although it is difficult to ascertain whether the increase in FAO 
was more similar to a single prolonged bout of contractile activity or short-term exercise 
training, there is evidence for both.  Media glucose did not differ between control and stimulated 
cultures, yet lactate was elevated in the stimulated group throughout the 48 h period (Figures 
2.6A & B).  An attractive explanation for these findings would be that the continuous nature of 
the 48 h stimulation bout is similar to a single prolonged training bout in that they both promote 
the breakdown of glycogen.  In turn, increased glycogenolysis would contribute to the elevated 
media lactate and as a result of reductions in glycogen content, FAO increased to meet energy 
demand.  Evidence supporting the hypothesis that, in culture, glucose is preferentially utilized at 
the expense of FAO comes from several electrical stimulation investigations that have 
demonstrated glucose uptake or oxidation increases after 30 min (145), 1 h (117), 8 h (107), 24 h 
(131), and 48 h (131).  On the other hand, in the investigations containing prolonged continuous 
stimulation bouts, FAO did not increase after 24 h (107, 131) but did so after 48 h (131).  The 
observation that FAO did not increase after 24 h but did so after 48 h may be similar to in vivo 
exercise data, in which the initial increase in FAO during the early stages of exercise is relatively 
small compared to the substantial increase in FAO during the later stages of an extended 
prolonged exercise bout.  For example, Bradley et al (24) demonstrated that when recreationally 
active individuals cycled for 120 min at 60% VO2 peak, FAO remains relatively constant from 
the initial stages of exercise through 80 min before increasing between 80 and 120 min (24).  The 
increased reliance on FAO during the later stages of exercise likely coincides with a depletion in 
glycogen content.  Taken together, the data from this investigation seems to indicate that in vitro 
  
 
80 
contractile activity is capable of increasing glucose utilization, and if performed over an 
extended period of time (48 h), may increase FAO as well.  
 Alternatively, an early response to short-term aerobic training (1-3 d) in vivo is an 
increase in the monocarboxylate transporters (MCT) (70, 71), which are responsible for 
exchanging pyruvate for lactate across the sarcolemma.  In the present investigation, elevated 
media lactate may have simply been the result of an increased exchange of media pyruvate for 
myocyte lactate due to elevated myocyte MTC expression, rather than increased glycogenolysis. 
Although not measured here, if true, increased MCT expression after a single 48 h bout of 
stimulation would support this model as being similar to short-term exercise training instead of 
simply a single extended exercise bout.  
 The increase in FAO in the present investigation may have been an early adaptation in 
fuel selection in response to the continuous 48 h short-term training bout, as demonstrated in 
previous short-term (7-10 d) in vivo exercise training studies (10, 14).  In the present 
investigation, FAO was measured approximately 15 hours after the termination of the 48 h 
stimulation bout and although glycogen content was not measured, it is plausible that glycogen 
content was replenished during this time; implicating a mechanism other than glycogen depletion 
to be responsible for the observed increase in FAO.  Our laboratory has demonstrated FAO 
increases in response to seven consecutive days of aerobic training (10), however, to date no 
investigations have looked into the effects of short-term aerobic training of less than seven days 
on FAO, highlighting the need for future research during this time frame. 
 Taken together, it appears that 48 h of continuous electrical stimulation may be of a 
sufficient duration to increase FAO, but not great enough to illicit increased OXPHOS protein 
content, respiratory capacity, or decreased lactate accumulation.  In those regards, 48 h of 
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continuous electrical stimulation recapitulates many of the effects of a single acute bout of 
prolonged aerobic exercise but is unable to mimic many of the effects of short-term aerobic 
training.  For the complete effects of short-term training including increased skeletal muscle 
oxidative capacity to be observed, future electrical stimulation investigations in HSkMC should 
extend the stimulation period beyond 48 h.  Doing so, may elucidate the timeline and 
mechanisms behind an increase in FAO due to short-term aerobic training before and during the 
time adaptations in oxidative machinery occur.  
The Effect of the Addition of Oxidizable Substrates on Metabolic Flexibility 
 The second aim of this investigation was to determine whether HSkMC from severely 
obese donors were similarly metabolically inflexible in response to a CHO (galactose or 
pyruvate) overload as they are to a lipid challenge.  The primary finding of this investigation was 
that, in culture, the skeletal muscle of the severely obese individual is metabolically flexible as it 
retains the ability to upregulate OXPHOS protein (Figures 3.2A-B), CS (Figures 3.2A-B), and 
oxidative capacity (Figures 3.3A-C) in response to not only galactose and pyruvate, but lipid as 
well.  These findings are in contrast to previous data generated in our laboratory demonstrating 
that lean, but not obese, increase the capacity of state 3, palmitoyl-carnitine malate supported 
respiration (PCM3) (23) in response to a lipid incubation.  Differences in methodology and 
inherent human subject variability are likely contributors to these differences.  The results of the 
current investigation support the hypothesis that metabolic flexibility is an inherent trait of 
skeletal muscle and that extramuscular mechanisms may be responsible for the metabolic 
inflexibility observed in vivo (61).  It is therefore imperative to compare and contrast the in vitro 
and in vivo experimental results to gain a better understanding of the factors controlling 
metabolic flexibility. 
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 Metabolic flexibility is broadly defined as the ability to match nutrient oxidation with 
nutrient availability.  The two most common means of testing metabolic flexibility in vivo are a) 
a hyperinsulinemic clamp and b) the imposition of a high fat diet (HFD).  In the late 1990’s 
David Kelley’s group found that, compared to their lean counterparts, obese individuals rely 
more heavily on glucose oxidation during times of fasting and less on glucose oxidation during 
insulin stimulation (94, 96).  Galgani et al (57) has attributed the metabolic inflexibility in obese 
and diabetic individuals described by Kelley et al (94) primarily to insulin resistance, as normal 
metabolic flexibility is exhibited when metabolic flexibility is normalized to glucose uptake.  
The design (no insulin) and results of the current investigation are more similar to the HFD 
literature and as such will be discussed in the context of previous HFD studies.   
 With the imposition of a HFD obese individuals are thought to match nutrient oxidation 
with substrate availability (upregulate FAO) more slowly than their lean counterparts (182).  The 
delay in time between the increase in dietary fat and the time required to match nutrient 
oxidation with substrate availability may cause the obese individual to store more and oxidize 
less fat resulting in a positive fat balance (167, 182).  Numerous, repetitive bouts of these 
“mismatches” are thought to lead to increased adiposity and weight gain.  On the other hand, 
lean individuals adapt to the HFD more rapidly thereby minimizing the opportunity for positive 
fat balances to occur.   
 There are, however, several instances where the lean individual does not respond to 
increases in dietary fat.  For example, in young, lean individuals, Schutz et al (162) 
supplemented a normal mixed diet for 24 h with 987 kcal of fat (52% of total energy) and noted 
no change in the subsequent 36 h RQ indicating no increase in FAO.  When CHO continues to 
be present, in adequate quantities, substrate utilization will not change from CHO to fatty acids 
  
 
83 
regardless of the amount of dietary fat.  In an overfeeding study, 40 nonobese men and women 
were overfed ~1040 kcal for 3 d.  RQ actually increased, from 0.81 to 0.85 despite 46% of kcal 
provided derived from fat (156).  When CHO intake is controlled, as in a isocaloric HFD, it may 
take up to 7 d for lean individuals to completely upregulate FAO to match fat intake (161).  
When exercise is superimposed upon a HFD in lean individuals, a lower steady state RQ is 
reached at 3 d compared to the HFD alone (166).  This seems to indicate that physical activity is 
an important factor in determining how quickly an individual responds to the HFD.   
 Schrauwen et al (160) has demonstrated that obese individuals are capable of adapting to 
a HFD within 36 h when a glycogen exhausting exercise bout (~60 min) is performed prior to the 
initiation of a HFD.  From the results of this study, Schrauwen et al (160) concludes “the results 
of the present study demonstrate that obese subjects are capable of rapidly adjusting fat oxidation 
to fat intake when glycogen stores are lowered.  Therefore, these results are in concordance with 
the results obtained in lean subjects and do not provide evidence for an impaired capacity to 
rapidly change fat oxidation in obese subjects.”   
 In addition, not all HFD studies have demonstrated a blunted ability for obese individuals 
to upregulate FAO in response to increased dietary lipid alone.  In a group of moderately obese 
individuals (BMI 35.9 ± 4.9), Bergouignan et al (17) indicated that switching from a 20% to 50% 
HFD for 2 d decreased 24 h whole body RQ and increased markers of skeletal muscle oxidative 
capacity in lean and obese individuals to a similar extent.  There were also no differences in 
CHO or fat balances noted between the groups, indicating the potential for weight gain between 
groups was equivalent.  A strength of the Bergouignan et al (17) study is that it was conducted in 
a metabolic chamber.  Therefore, a subject’s activity level and daily caloric expenditure can be 
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carefully monitored and controlled.  Free-living experiments afford no such control allowing the 
opportunity for unintentional differences in energy expenditure to occur (17, 92, 110, 111).   
 From the studies of Bergouignan et al (17) and Schrauwen et al (160) it would appear that 
when diet and physical activity are meticulously controlled, the ability of skeletal muscle from 
lean and obese individuals to respond similarly to oxidizable substrates should not be 
unexpected.  In the cell culture model when glucose concentrations, insulin, and fatty acid 
concentrations are identical between the lean and the obese, metabolic flexibility remains intact.  
The findings in the current investigation support the notion that regulation, not oxidative 
capacity, dictates metabolic flexibility (57, 61).  It should be pointed out however, that although 
not statistically significant, the obese groups in the present study and the Gaster et al (61) 
investigation demonstrated decreased responsiveness to metabolic stimuli.  It is possible that 
increasing the concentration of lipid may have shown a lean-obese effect.  How this contributes 
to obesity will continue to be a debate.    
The Role of Energy Balance and Carbohydrate in the Development of Obesity 
 The effect of fatty acid oxidation on weight gain and weight loss remains controversial.  
There are as many published reports indicating that a high RQ is associated with or predictive of 
future weight gain (25, 43, 47, 49, 118, 119, 153, 164, 191, 211) as there are that report no 
association (93, 113, 163, 179, 197-199, 202, 203). The investigations linking elevated RQ 
values with future weight gain, although significant, tend to explain less than 30% of the 
variance (49, 119, 164, 211) in weight gain between individuals.  On the other hand, Weinsier et 
al (197) followed two groups of women over the course of 1 yr to determine characteristics 
associated with the propensity to regain weight and found that those who regained a substantial 
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portion of weight lost (>10%) had significantly reduced rates of free-living activity energy 
expenditure which explained an astonishing 77% of their weight regain. 
 The evidence for reduced FAO in the presence of obesity is also unclear.  For example, 
our laboratory has demonstrated that moderately obese (BMI, 30.2 ± 0.8 kg.m2) individuals do 
not have diminished rates of FAO whereas severely obese (BMI, 53.8  ± 0.4 kg.m2) individuals 
possess much lower rates (88) suggesting that in severe, but not moderate obesity, FAO is 
diminished.  On the other hand, whole body FAO determined by RQ have demonstrated that 
subjects with BMI values of 49 ± 2 kg/m2 (124) and 56.3 ± 2.7 kg/m2 (137) have very high rates 
of FAO.  Blaak et al (20) stratified a group of 701 obese individuals into BMI categories of 30-
35, 35-40 and >40 kg/m2 and found that as BMI increased, so did fasting FAO whether 
unadjusted, adjusted for fat free mass or expressed as a percentage of resting energy expenditure.  
Human primary skeletal muscle cell culture (HSkMC) has also yielded conflicting results as 
some studies (11, 36, 37, 62, 87) but not others (31, 61, 171) have shown decreased rates of 
FAO.  Taken together, it is difficult to ascertain whether FAO is reduced in the obese state and if 
decrements in FAO are present, whether this is a cause or a consequence of obesity. 
  High fat diets are a commonly used tool in the study of obesity and its relationship to 
metabolic flexibility.  Although HFD’s are a useful experimental model, the results of such 
studies should be interpreted with caution, as they do not accurately reflect the dietary habits of 
the public.  In the past 40 years the prevalence of adult obesity in the United States has increased 
dramatically from 11.9% to 35.5% in men and from 16.6% to 35.8% in women (53, 54).  
According to National Health and Nutrition Examination Survey (NHANES) data, during that 
same time CHO intake has increased from 44.0% to 48.7% and fat intake has actually decreased 
from 36.6% to 33.7% (7).  There are also no reported differences in the macronutrient intake 
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between lean, overweight, and obese individuals, however, each group has significantly 
increased total caloric intake over the previous 40 years (7).  The efficacy of utilizing a multiple 
day high fat diet containing greater than 50% does not accurately reflect dietary habits in the 
United States.  For example, outside of salad dressing and condiments the fast food restaurant, 
McDonalds, does not contain a single item containing > 59% fat.  People typically consume 
sugary beverages and French fries as part of their meal, further decreasing the contribution of 
dietary fat from the meal as a whole.  
 It has been suggested that severely obese and diabetic individuals possess an inherent 
defect in skeletal muscle that prevents them from oxidizing fatty acids to the same extent as lean 
individuals.  Perhaps a new paradigm would suggest that obese individuals do not oxidize fatty 
acids because they are not required to do so. There is overwhelming evidence that macronutrient 
oxidation is governed by an “oxidative hierarchy”.  When CHO is present in the diet, CHO is 
preferentially oxidized at the expense of FAO.  Obesity is the result of a prolonged energy 
imbalance between energy intake and expenditure.  Diets high in fat tend to also contain a 
greater number of calories due to the caloric density of fat.  For example, when subjects were 
asked to eat ad libitum from diets containing low-fat, medium-fat, and high-fat without 
knowledge of the macronutrient composition, energy intakes significantly increased with percent 
fat (173).  Continual access to food and opportunities to eat ensures that CHO stores are never 
diminished to the point where an increased reliance on fatty acids is necessary.  Although the 
percentage of fat in the diet decreased during the past 40 yrs, the total amount of fat in grams 
remained the same (7).  During this same time, the proportion of calories coming from CHO has 
increased from 44.0% to 48.7%, giving the body no other choice than to use CHO and not 
oxidize fat. 
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Conclusion 
 Due to the environment we live in, it is difficult to not become overweight or obese in the 
United States (53, 140).  During the past 40 yrs the prevalence of obesity has tripled in the 
United State while the consumption of dietary fat has actually decreased (7).  In epidemiological 
studies, countries with the highest per capita fat intake oftentimes do not have the most obese 
population (113).  Yet, we are still focusing our efforts to reduce body weight through targeting 
dietary fat and fatty acid oxidation.  The real culprit in the obesity crisis is not fat it is 
carbohydrate.  Although probably oversimplistic, Flatt’s two- compartment model forms the lens 
though which obesity should be viewed (51).  The body’s initial defense against changes in body 
weight homeostasis is glycogen content and/or a high carbohydrate availability.  When glycogen 
stores are plentiful, CHO is the preferred fuel choice, when glycogen stores are depleted, fat 
becomes the preferred fuel of choice.  It is not until glycogen content and carbohydrate 
availability is lowered, through fasting, diet and/or exercise that fat stores can begin to be 
depleted.  High fat diets are used by individuals to lose weight (60, 86, 155) but are also blamed 
for individuals to gain weight (25).  This highlights the importance of energetic balance, not 
macronutrient composition.  Metabolic flexibility may (5) or may not (17, 122) cause fat 
imbalances in the short term, however the results of these studies are inconsistent with and not 
reflective of the average individual’s dietary habits.  HFD studies often use in excess of 60% of 
calories from dietary fat (3, 10, 19, 22).  A concerted effort is required to achieve ≥ 50% of 
calories from fat in the typical diet; even Atkins and South Beach dieters have trouble 
consistently achieving this mark (60, 116).  It is indisputable that aerobic exercise increases 
oxidative capacity and confers numerous health benefits.  The ability of exercise to change 
resting substrate utilization is less clear.  Exercise should be used as a tool to expend energy and 
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deplete glycogen stores, which may aid in achieving weight loss.  Regardless of whether you 
exercise a lot or not at all, eat a diet consisting of a high percentage of fat or very little, energetic 
balance is the key to weight loss and weight gain. 
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